{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T15:21:44Z","timestamp":1791559304596,"version":"4.3.4"},"reference-count":359,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,1,20]],"date-time":"2023-01-20T00:00:00Z","timestamp":1674172800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,1,20]],"date-time":"2023-01-20T00:00:00Z","timestamp":1674172800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Biosci"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Brain\u2013heart interaction has raised up increasing attentions. Nuclear receptors (NRs) are abundantly expressed in the brain, and emerging evidence indicates that a number of these brain NRs regulate multiple aspects of cardiovascular diseases\u00a0(CVDs), including hypertension, heart failure, atherosclerosis, etc. In this review, we will elaborate recent findings that have established the physiological relevance of brain NRs in the context of cardiovascular function. In addition, we will discuss the currently available evidence regarding the distinct neuronal populations that respond to brain NRs in the cardiovascular control. These findings suggest connections between cardiac control and brain dynamics through NR signaling, which may lead to novel tools for the treatment of pathological changes in the CVDs.<\/jats:p>","DOI":"10.1186\/s13578-023-00962-3","type":"journal-article","created":{"date-parts":[[2023,1,21]],"date-time":"2023-01-21T02:26:33Z","timestamp":1674267993000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Brain nuclear receptors and cardiovascular function"],"prefix":"10.1186","volume":"13","author":[{"given":"Mengjie","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongjie","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4908-1572","authenticated-orcid":false,"given":"Yong","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,1,20]]},"reference":[{"issue":"pt 4","key":"962_CR1","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1242\/jcs.00247","volume":"116","author":"M Robinson-Rechavi","year":"2003","unstructured":"Robinson-Rechavi M, Escriva Garcia H, Laudet V. The nuclear receptor superfamily. J Cell Sci. 2003;116(pt 4):585\u20136. https:\/\/doi.org\/10.1242\/jcs.00247.","journal-title":"J Cell Sci"},{"issue":"2","key":"962_CR2","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/j.steroids.2006.12.001","volume":"72","author":"VM Popov","year":"2007","unstructured":"Popov VM, et al. The functional significance of nuclear receptor acetylation. Steroids. 2007;72(2):221\u201330.","journal-title":"Steroids"},{"issue":"3","key":"962_CR3","doi-asserted-by":"publisher","first-page":"1269","DOI":"10.1152\/physrev.2001.81.3.1269","volume":"81","author":"A Aranda","year":"2001","unstructured":"Aranda A, Pascual A. Nuclear hormone receptors and gene expression. Physiol Rev. 2001;81(3):1269\u2013304.","journal-title":"Physiol Rev"},{"issue":"4","key":"962_CR4","doi-asserted-by":"publisher","first-page":"236","DOI":"10.4103\/2231-4040.90879","volume":"2","author":"S Tyagi","year":"2011","unstructured":"Tyagi S, et al. The peroxisome proliferator-activated receptor: a family of nuclear receptors role in various diseases. J Adv Pharm Technol Res. 2011;2(4):236\u201340.","journal-title":"J Adv Pharm Technol Res"},{"issue":"6","key":"962_CR5","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1161\/01.RES.0000141774.29937.e3","volume":"95","author":"JM Huss","year":"2004","unstructured":"Huss JM, Kelly DP. Nuclear receptor signaling and cardiac energetics. Circ Res. 2004;95(6):568\u201378.","journal-title":"Circ Res"},{"issue":"1","key":"962_CR6","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.pharmthera.2012.03.007","volume":"135","author":"AA Knowlton","year":"2012","unstructured":"Knowlton AA, Lee AR. Estrogen and the cardiovascular system. Pharmacol Ther. 2012;135(1):54\u201370.","journal-title":"Pharmacol Ther"},{"issue":"5","key":"962_CR7","doi-asserted-by":"publisher","first-page":"2055","DOI":"10.1210\/en.2002-221069","volume":"144","author":"SW Mitra","year":"2003","unstructured":"Mitra SW, et al. Immunolocalization of estrogen receptor beta in the mouse brain: comparison with estrogen receptor alpha. Endocrinology. 2003;144(5):2055\u201367.","journal-title":"Endocrinology"},{"issue":"1","key":"962_CR8","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1002\/cne.902940107","volume":"294","author":"RB Simerly","year":"1990","unstructured":"Simerly RB, et al. Distribution of androgen and estrogen receptor mRNA-containing cells in the rat brain: an in situ hybridization study. J Comp Neurol. 1990;294(1):76\u201395.","journal-title":"J Comp Neurol"},{"issue":"5","key":"962_CR9","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1136\/jcp.55.5.371","volume":"55","author":"V Speirs","year":"2002","unstructured":"Speirs V, et al. Distinct expression patterns of ER alpha and ER beta in normal human mammary gland. J Clin Pathol. 2002;55(5):371\u20134.","journal-title":"J Clin Pathol"},{"issue":"3","key":"962_CR10","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1002\/1096-9861(20000925)425:3<422::AID-CNE7>3.0.CO;2-H","volume":"425","author":"A Fernandez-Guasti","year":"2000","unstructured":"Fernandez-Guasti A, et al. Sex differences in the distribution of androgen receptors in the human hypothalamus. J Comp Neurol. 2000;425(3):422\u201335.","journal-title":"J Comp Neurol"},{"issue":"3","key":"962_CR11","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1152\/advan.00027.2016","volume":"40","author":"RA Dampney","year":"2016","unstructured":"Dampney RA. Central neural control of the cardiovascular system: current perspectives. Adv Physiol Educ. 2016;40(3):283\u201396.","journal-title":"Adv Physiol Educ"},{"key":"962_CR12","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1186\/1423-0127-16-60","volume":"16","author":"CD Shih","year":"2009","unstructured":"Shih CD. Activation of estrogen receptor beta-dependent nitric oxide signaling mediates the hypotensive effects of estrogen in the rostral ventrolateral medulla of anesthetized rats. J Biomed Sci. 2009;16:60.","journal-title":"J Biomed Sci"},{"issue":"6","key":"962_CR13","doi-asserted-by":"publisher","first-page":"1255","DOI":"10.1161\/HYPERTENSIONAHA.111.00903","volume":"61","author":"B Xue","year":"2013","unstructured":"Xue B, et al. Estrogen receptor-beta in the paraventricular nucleus and rostroventrolateral medulla plays an essential protective role in aldosterone\/salt-induced hypertension in female rats. Hypertension. 2013;61(6):1255\u201362.","journal-title":"Hypertension"},{"issue":"1","key":"962_CR14","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1172\/JCI65252","volume":"123","author":"J Mittag","year":"2013","unstructured":"Mittag J, et al. Thyroid hormone is required for hypothalamic neurons regulating cardiovascular functions. J Clin Invest. 2013;123(1):509\u201316.","journal-title":"J Clin Invest"},{"issue":"1","key":"962_CR15","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1186\/s13054-020-02885-8","volume":"24","author":"D Battaglini","year":"2020","unstructured":"Battaglini D, et al. Brain\u2013heart interaction after acute ischemic stroke. Crit Care. 2020;24(1):163.","journal-title":"Crit Care"},{"issue":"4","key":"962_CR16","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1161\/CIRCRESAHA.117.311170","volume":"121","author":"Z Chen","year":"2017","unstructured":"Chen Z, et al. Brain\u2013heart interaction: cardiac complications after stroke. Circ Res. 2017;121(4):451\u201368.","journal-title":"Circ Res"},{"issue":"6","key":"962_CR17","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1161\/CIRCRESAHA.110.236687","volume":"109","author":"E Murphy","year":"2011","unstructured":"Murphy E. Estrogen signaling and cardiovascular disease. Circ Res. 2011;109(6):687\u201396.","journal-title":"Circ Res"},{"issue":"23","key":"962_CR18","doi-asserted-by":"publisher","first-page":"1801","DOI":"10.1056\/NEJM199906103402306","volume":"340","author":"ME Mendelsohn","year":"1999","unstructured":"Mendelsohn ME, Karas RH. The protective effects of estrogen on the cardiovascular system. N Engl J Med. 1999;340(23):1801\u201311.","journal-title":"N Engl J Med"},{"issue":"12A","key":"962_CR19","doi-asserted-by":"publisher","first-page":"12E","DOI":"10.1016\/S0002-9149(02)02405-0","volume":"89","author":"ME Mendelsohn","year":"2002","unstructured":"Mendelsohn ME. Protective effects of estrogen on the cardiovascular system. Am J Cardiol. 2002;89(12A):12E-17E; discussion 17E-18E.","journal-title":"Am J Cardiol"},{"issue":"1","key":"962_CR20","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/s13293-017-0152-8","volume":"8","author":"A Iorga","year":"2017","unstructured":"Iorga A, et al. The protective role of estrogen and estrogen receptors in cardiovascular disease and the controversial use of estrogen therapy. Biol Sex Differ. 2017;8(1):33.","journal-title":"Biol Sex Differ"},{"issue":"4","key":"962_CR21","first-page":"e29","volume":"131","author":"D Mozaffarian","year":"2015","unstructured":"Mozaffarian D, et al. Heart disease and stroke statistics\u20132015 update: a report from the American Heart Association. Circulation. 2015;131(4):e29-322.","journal-title":"Circulation"},{"issue":"5","key":"962_CR22","doi-asserted-by":"publisher","first-page":"1199","DOI":"10.1161\/01.HYP.37.5.1199","volume":"37","author":"JF Reckelhoff","year":"2001","unstructured":"Reckelhoff JF. Gender differences in the regulation of blood pressure. Hypertension. 2001;37(5):1199\u2013208.","journal-title":"Hypertension"},{"issue":"1","key":"962_CR23","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1024\/0301-1526\/a000490","volume":"45","author":"K Stoberock","year":"2016","unstructured":"Stoberock K, et al. Gender differences in patients with carotid stenosis. Vasa. 2016;45(1):11\u20136.","journal-title":"Vasa"},{"issue":"7","key":"962_CR24","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1038\/sj.jhh.1001431","volume":"16","author":"K Kawecka-Jaszcz","year":"2002","unstructured":"Kawecka-Jaszcz K, et al. The effect of hormone replacement therapy on arterial blood pressure and vascular compliance in postmenopausal women with arterial hypertension. J Hum Hypertens. 2002;16(7):509\u201316.","journal-title":"J Hum Hypertens"},{"key":"962_CR25","doi-asserted-by":"publisher","first-page":"2158971","DOI":"10.1155\/2016\/2158971","volume":"2016","author":"F Hao","year":"2016","unstructured":"Hao F, et al. Estrogen replacement reduces oxidative stress in the rostral ventrolateral medulla of ovariectomized rats. Oxid Med Cell Longev. 2016;2016:2158971.","journal-title":"Oxid Med Cell Longev"},{"issue":"5","key":"962_CR26","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1016\/j.cjca.2021.02.005","volume":"37","author":"PJ Connelly","year":"2021","unstructured":"Connelly PJ, et al. The importance of gender to understand sex differences in cardiovascular disease. Can J Cardiol. 2021;37(5):699\u2013710.","journal-title":"Can J Cardiol"},{"issue":"1","key":"962_CR27","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1152\/physrev.00021.2015","volume":"97","author":"V Regitz-Zagrosek","year":"2017","unstructured":"Regitz-Zagrosek V, Kararigas G. Mechanistic pathways of sex differences in cardiovascular disease. Physiol Rev. 2017;97(1):1\u201337.","journal-title":"Physiol Rev"},{"issue":"12","key":"962_CR28","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1016\/S0039-128X(02)00040-5","volume":"67","author":"T Simoncini","year":"2002","unstructured":"Simoncini T, et al. Novel non-transcriptional mechanisms for estrogen receptor signaling in the cardiovascular system. Steroids. 2002;67(12):935\u20139. https:\/\/doi.org\/10.1016\/S0039-128X(02)00040-5.","journal-title":"Steroids"},{"issue":"6","key":"962_CR29","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1016\/S1471-4892(01)00105-9","volume":"1","author":"SO Mueller","year":"2001","unstructured":"Mueller SO, Korach KS. Estrogen receptors and endocrine diseases: lessons from estrogen receptor knockout mice. Curr Opin Pharmacol. 2001;1(6):613\u20139.","journal-title":"Curr Opin Pharmacol"},{"issue":"11","key":"962_CR30","doi-asserted-by":"publisher","first-page":"4613","DOI":"10.1210\/endo.138.11.5496","volume":"138","author":"JF Couse","year":"1997","unstructured":"Couse JF, et al. Tissue distribution and quantitative analysis of estrogen receptor-alpha (ERalpha) and estrogen receptor-beta (ERbeta) messenger ribonucleic acid in the wild-type and ERalpha-knockout mouse. Endocrinology. 1997;138(11):4613\u201321.","journal-title":"Endocrinology"},{"issue":"3","key":"962_CR31","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1210\/edrv.20.3.0370","volume":"20","author":"JF Couse","year":"1999","unstructured":"Couse JF, Korach KS. Estrogen receptor null mice: what have we learned and where will they lead us? Endocr Rev. 1999;20(3):358\u2013417.","journal-title":"Endocr Rev"},{"issue":"5","key":"962_CR32","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1038\/nrn1902","volume":"7","author":"PG Guyenet","year":"2006","unstructured":"Guyenet PG. The sympathetic control of blood pressure. Nat Rev Neurosci. 2006;7(5):335\u201346.","journal-title":"Nat Rev Neurosci"},{"issue":"1","key":"962_CR33","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/j.brainres.2006.03.089","volume":"1094","author":"G Wang","year":"2006","unstructured":"Wang G, et al. Evidence that estrogen directly and indirectly modulates C1 adrenergic bulbospinal neurons in the rostral ventrolateral medulla. Brain Res. 2006;1094(1):163\u201378.","journal-title":"Brain Res"},{"issue":"6","key":"962_CR34","doi-asserted-by":"publisher","first-page":"R1560","DOI":"10.1152\/ajpregu.00020.2011","volume":"300","author":"M Subramanian","year":"2011","unstructured":"Subramanian M, et al. Chronic estradiol-17beta exposure increases superoxide production in the rostral ventrolateral medulla and causes hypertension: reversal by resveratrol. Am J Physiol Regul Integr Comp Physiol. 2011;300(6):R1560\u20138.","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"962_CR35","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1186\/1471-2202-14-134","volume":"14","author":"SK Lee","year":"2013","unstructured":"Lee SK, Ryu PD, Lee SY. Estrogen replacement modulates voltage-gated potassium channels in rat presympathetic paraventricular nucleus neurons. BMC Neurosci. 2013;14:134.","journal-title":"BMC Neurosci"},{"issue":"3","key":"962_CR36","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/S0165-1838(00)00087-4","volume":"80","author":"TM Saleh","year":"2000","unstructured":"Saleh TM, Connell BJ. 17beta-estradiol modulates baroreflex sensitivity and autonomic tone of female rats. J Auton Nerv Syst. 2000;80(3):148\u201361.","journal-title":"J Auton Nerv Syst"},{"issue":"12","key":"962_CR37","doi-asserted-by":"publisher","first-page":"4098","DOI":"10.2337\/db13-0282","volume":"62","author":"S Handgraaf","year":"2013","unstructured":"Handgraaf S, et al. Prevention of obesity and insulin resistance by estrogens requires ERalpha activation function-2 (ERalphaAF-2), whereas ERalphaAF-1 is dispensable. Diabetes. 2013;62(12):4098\u2013108.","journal-title":"Diabetes"},{"issue":"1","key":"962_CR38","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.tem.2010.10.002","volume":"22","author":"F Mauvais-Jarvis","year":"2011","unstructured":"Mauvais-Jarvis F. Estrogen and androgen receptors: regulators of fuel homeostasis and emerging targets for diabetes and obesity. Trends Endocrinol Metab. 2011;22(1):24\u201333.","journal-title":"Trends Endocrinol Metab"},{"issue":"4","key":"962_CR39","doi-asserted-by":"publisher","first-page":"1172","DOI":"10.1172\/JCI88891","volume":"127","author":"Y Xu","year":"2017","unstructured":"Xu Y, O\u2019Malley BW, Elmquist JK. Brain nuclear receptors and body weight regulation. J Clin Invest. 2017;127(4):1172\u201380.","journal-title":"J Clin Invest"},{"issue":"7","key":"962_CR40","doi-asserted-by":"publisher","first-page":"2861","DOI":"10.1172\/JCI80941","volume":"125","author":"P Xu","year":"2015","unstructured":"Xu P, et al. Estrogen receptor-alpha in medial amygdala neurons regulates body weight. J Clin Invest. 2015;125(7):2861\u201376.","journal-title":"J Clin Invest"},{"issue":"1","key":"962_CR41","doi-asserted-by":"publisher","first-page":"2165","DOI":"10.1038\/s41467-020-15982-7","volume":"11","author":"Y He","year":"2020","unstructured":"He Y, et al. Estrogen receptor-alpha expressing neurons in the ventrolateral VMH regulate glucose balance. Nat Commun. 2020;11(1):2165.","journal-title":"Nat Commun"},{"issue":"23","key":"962_CR42","doi-asserted-by":"publisher","first-page":"1689","DOI":"10.1056\/NEJMra000050","volume":"345","author":"KT Weber","year":"2001","unstructured":"Weber KT. Aldosterone in congestive heart failure. N Engl J Med. 2001;345(23):1689\u201397.","journal-title":"N Engl J Med"},{"issue":"19","key":"962_CR43","doi-asserted-by":"publisher","first-page":"2512","DOI":"10.1161\/01.CIR.0000071081.35693.9A","volume":"107","author":"NJ Brown","year":"2003","unstructured":"Brown NJ. Eplerenone: cardiovascular protection. Circulation. 2003;107(19):2512\u20138.","journal-title":"Circulation"},{"issue":"5","key":"962_CR44","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1016\/j.ejheart.2004.04.013","volume":"6","author":"AD Struthers","year":"2004","unstructured":"Struthers AD. The clinical implications of aldosterone escape in congestive heart failure. Eur J Heart Fail. 2004;6(5):539\u201345.","journal-title":"Eur J Heart Fail"},{"issue":"11","key":"962_CR45","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.1093\/ajh\/hpy120","volume":"31","author":"M Buonafine","year":"2018","unstructured":"Buonafine M, Bonnard B, Jaisser F. Mineralocorticoid receptor and cardiovascular disease. Am J Hypertens. 2018;31(11):1165\u201374.","journal-title":"Am J Hypertens"},{"issue":"4","key":"962_CR46","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1161\/CIRCULATIONAHA.109.915215","volume":"122","author":"SF Mohammed","year":"2010","unstructured":"Mohammed SF, et al. Mineralocorticoid accelerates transition to heart failure with preserved ejection fraction via \u201cnongenomic effects.\u201d Circulation. 2010;122(4):370\u20138.","journal-title":"Circulation"},{"issue":"1","key":"962_CR47","doi-asserted-by":"publisher","first-page":"191","DOI":"10.4049\/jimmunol.0802886","volume":"184","author":"AA Herrada","year":"2010","unstructured":"Herrada AA, et al. Aldosterone promotes autoimmune damage by enhancing Th17-mediated immunity. J Immunol. 2010;184(1):191\u2013202.","journal-title":"J Immunol"},{"issue":"4","key":"962_CR48","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1161\/HYPERTENSIONAHA.107.100941","volume":"51","author":"D Fraccarollo","year":"2008","unstructured":"Fraccarollo D, et al. Immediate mineralocorticoid receptor blockade improves myocardial infarct healing by modulation of the inflammatory response. Hypertension. 2008;51(4):905\u201314.","journal-title":"Hypertension"},{"issue":"14","key":"962_CR49","doi-asserted-by":"publisher","first-page":"1309","DOI":"10.1056\/NEJMoa030207","volume":"348","author":"B Pitt","year":"2003","unstructured":"Pitt B, et al. Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction. N Engl J Med. 2003;348(14):1309\u201321.","journal-title":"N Engl J Med"},{"issue":"1","key":"962_CR50","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1056\/NEJMoa1009492","volume":"364","author":"F Zannad","year":"2011","unstructured":"Zannad F, et al. Eplerenone in patients with systolic heart failure and mild symptoms. N Engl J Med. 2011;364(1):11\u201321.","journal-title":"N Engl J Med"},{"key":"962_CR51","doi-asserted-by":"publisher","DOI":"10.1621\/nrs.05012","volume":"5","author":"S Viengchareun","year":"2007","unstructured":"Viengchareun S, et al. The mineralocorticoid receptor: insights into its molecular and (patho)physiological biology. Nucl Recept Signal. 2007;5: e012.","journal-title":"Nucl Recept Signal"},{"issue":"5170","key":"962_CR52","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1038\/220911a0","volume":"220","author":"BS McEwen","year":"1968","unstructured":"McEwen BS, Weiss JM, Schwartz LS. Selective retention of corticosterone by limbic structures in rat brain. Nature. 1968;220(5170):911\u20132.","journal-title":"Nature"},{"issue":"6","key":"962_CR53","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1042\/EBC20210006","volume":"65","author":"MJ Young","year":"2021","unstructured":"Young MJ, Clyne CD. Mineralocorticoid receptor actions in cardiovascular development and disease. Essays Biochem. 2021;65(6):901\u201311.","journal-title":"Essays Biochem"},{"issue":"2","key":"962_CR54","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1097\/00041552-200403000-00007","volume":"13","author":"EP Gomez-Sanchez","year":"2004","unstructured":"Gomez-Sanchez EP. Brain mineralocorticoid receptors: orchestrators of hypertension and end-organ disease. Curr Opin Nephrol Hypertens. 2004;13(2):191\u20136.","journal-title":"Curr Opin Nephrol Hypertens"},{"issue":"3","key":"962_CR55","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1007\/s11906-011-0192-0","volume":"13","author":"BS Huang","year":"2011","unstructured":"Huang BS, Leenen FH. Mineralocorticoid actions in the brain and hypertension. Curr Hypertens Rep. 2011;13(3):214\u201320.","journal-title":"Curr Hypertens Rep"},{"issue":"4","key":"962_CR56","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1038\/kisup.2013.65","volume":"3","author":"FP Cappuccio","year":"2013","unstructured":"Cappuccio FP. Cardiovascular and other effects of salt consumption. Kidney Int Suppl (2011). 2013;3(4):312\u20135.","journal-title":"Kidney Int Suppl (2011)."},{"key":"962_CR57","doi-asserted-by":"publisher","first-page":"164","DOI":"10.3389\/fendo.2016.00164","volume":"7","author":"YW Kong","year":"2016","unstructured":"Kong YW, et al. Sodium and its role in cardiovascular disease\u2014the debate continues. Front Endocrinol (Lausanne). 2016;7:164.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"3","key":"962_CR58","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1002\/cne.20808","volume":"494","author":"JC Geerling","year":"2006","unstructured":"Geerling JC, Kawata M, Loewy AD. Aldosterone-sensitive neurons in the rat central nervous system. J Comp Neurol. 2006;494(3):515\u201327.","journal-title":"J Comp Neurol"},{"issue":"3","key":"962_CR59","doi-asserted-by":"publisher","first-page":"R252","DOI":"10.1152\/ajpregu.00385.2011","volume":"304","author":"S Formenti","year":"2013","unstructured":"Formenti S, et al. Hindbrain mineralocorticoid mechanisms on sodium appetite. Am J Physiol Regul Integr Comp Physiol. 2013;304(3):R252\u20139.","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"issue":"1","key":"962_CR60","doi-asserted-by":"publisher","first-page":"R61","DOI":"10.1152\/ajpregu.00434.2013","volume":"306","author":"B Koneru","year":"2014","unstructured":"Koneru B, et al. Mineralocorticoid receptor in the NTS stimulates saline intake during fourth ventricular infusions of aldosterone. Am J Physiol Regul Integr Comp Physiol. 2014;306(1):R61\u20136.","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"issue":"2","key":"962_CR61","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1016\/j.appet.2007.01.015","volume":"49","author":"EG Krause","year":"2007","unstructured":"Krause EG, Sakai RR. Richter and sodium appetite: from adrenalectomy to molecular biology. Appetite. 2007;49(2):353\u201367.","journal-title":"Appetite"},{"issue":"3","key":"962_CR62","doi-asserted-by":"publisher","first-page":"F559","DOI":"10.1152\/ajprenal.90399.2008","volume":"297","author":"JC Geerling","year":"2009","unstructured":"Geerling JC, Loewy AD. Aldosterone in the brain. Am J Physiol Renal Physiol. 2009;297(3):F559\u201376.","journal-title":"Am J Physiol Renal Physiol"},{"issue":"4","key":"962_CR63","doi-asserted-by":"publisher","first-page":"1337","DOI":"10.1046\/j.1523-1755.2000.00972.x","volume":"57","author":"RR Sakai","year":"2000","unstructured":"Sakai RR, et al. The amygdala: site of genomic and nongenomic arousal of aldosterone-induced sodium intake. Kidney Int. 2000;57(4):1337\u201345.","journal-title":"Kidney Int"},{"issue":"2 Pt 1","key":"962_CR64","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/S0002-8703(98)70081-X","volume":"135","author":"M Gomberg-Maitland","year":"1998","unstructured":"Gomberg-Maitland M, Frishman WH. Thyroid hormone and cardiovascular disease. Am Heart J. 1998;135(2 Pt 1):187\u201396.","journal-title":"Am Heart J"},{"issue":"3","key":"962_CR65","first-page":"139","volume":"29","author":"S Danzi","year":"2004","unstructured":"Danzi S, Klein I. Thyroid hormone and the cardiovascular system. Minerva Endocrinol. 2004;29(3):139\u201350.","journal-title":"Minerva Endocrinol"},{"issue":"15","key":"962_CR66","doi-asserted-by":"publisher","first-page":"1725","DOI":"10.1161\/CIRCULATIONAHA.106.678326","volume":"116","author":"I Klein","year":"2007","unstructured":"Klein I, Danzi S. Thyroid disease and the heart. Circulation. 2007;116(15):1725\u201335.","journal-title":"Circulation"},{"issue":"2","key":"962_CR67","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1007\/s10557-019-06870-4","volume":"33","author":"C Vale","year":"2019","unstructured":"Vale C, et al. The role of thyroid hormones in heart failure. Cardiovasc Drugs Ther. 2019;33(2):179\u201388.","journal-title":"Cardiovasc Drugs Ther"},{"issue":"2","key":"962_CR68","doi-asserted-by":"publisher","first-page":"55","DOI":"10.14797\/mdcj-13-2-55","volume":"13","author":"M Udovcic","year":"2017","unstructured":"Udovcic M, et al. Hypothyroidism and the heart. Methodist Debakey Cardiovasc J. 2017;13(2):55\u20139.","journal-title":"Methodist Debakey Cardiovasc J"},{"issue":"4","key":"962_CR69","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1161\/CIRCULATIONAHA.109.917922","volume":"122","author":"AM Gerdes","year":"2010","unstructured":"Gerdes AM, Iervasi G. Thyroid replacement therapy and heart failure. Circulation. 2010;122(4):385\u201393.","journal-title":"Circulation"},{"issue":"1","key":"962_CR70","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1007\/s12020-019-02050-4","volume":"66","author":"S Razvi","year":"2019","unstructured":"Razvi S. Novel uses of thyroid hormones in cardiovascular conditions. Endocrine. 2019;66(1):115\u201323.","journal-title":"Endocrine"},{"issue":"16","key":"962_CR71","doi-asserted-by":"publisher","first-page":"1781","DOI":"10.1016\/j.jacc.2018.02.045","volume":"71","author":"S Razvi","year":"2018","unstructured":"Razvi S, et al. Thyroid hormones and cardiovascular function and diseases. J Am Coll Cardiol. 2018;71(16):1781\u201396.","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"962_CR72","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1038\/nrcardio.2016.174","volume":"14","author":"A Jabbar","year":"2017","unstructured":"Jabbar A, et al. Thyroid hormones and cardiovascular disease. Nat Rev Cardiol. 2017;14(1):39\u201355.","journal-title":"Nat Rev Cardiol"},{"issue":"2","key":"962_CR73","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1016\/j.ecl.2014.02.005","volume":"43","author":"S Danzi","year":"2014","unstructured":"Danzi S, Klein I. Thyroid disease and the cardiovascular system. Endocrinol Metab Clin N Am. 2014;43(2):517\u201328.","journal-title":"Endocrinol Metab Clin N Am"},{"key":"962_CR74","doi-asserted-by":"publisher","first-page":"146","DOI":"10.3389\/fendo.2014.00146","volume":"5","author":"P Berbel","year":"2014","unstructured":"Berbel P, Navarro D, Roman GC. An evo-devo approach to thyroid hormones in cerebral and cerebellar cortical development: etiological implications for autism. Front Endocrinol (Lausanne). 2014;5:146.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"3","key":"962_CR75","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1038\/ncpendmet0424","volume":"3","author":"J Bernal","year":"2007","unstructured":"Bernal J. Thyroid hormone receptors in brain development and function. Nat Clin Pract Endocrinol Metab. 2007;3(3):249\u201359.","journal-title":"Nat Clin Pract Endocrinol Metab"},{"issue":"3","key":"962_CR76","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1085\/jgp.92.3.331","volume":"92","author":"R Hahin","year":"1988","unstructured":"Hahin R. Removal of inactivation causes time-invariant sodium current decays. J Gen Physiol. 1988;92(3):331\u201350.","journal-title":"J Gen Physiol"},{"issue":"10","key":"962_CR77","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1038\/nrendo.2014.143","volume":"10","author":"TM Ortiga-Carvalho","year":"2014","unstructured":"Ortiga-Carvalho TM, Sidhaye AR, Wondisford FE. Thyroid hormone receptors and resistance to thyroid hormone disorders. Nat Rev Endocrinol. 2014;10(10):582\u201391.","journal-title":"Nat Rev Endocrinol"},{"key":"962_CR78","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1016\/bs.ctdb.2017.01.001","volume":"125","author":"F Flamant","year":"2017","unstructured":"Flamant F, Gauthier K, Richard S. Genetic investigation of thyroid hormone receptor function in the developing and adult brain. Curr Top Dev Biol. 2017;125:303\u201335.","journal-title":"Curr Top Dev Biol"},{"issue":"18","key":"962_CR79","doi-asserted-by":"publisher","first-page":"7250","DOI":"10.1073\/pnas.86.18.7250","volume":"86","author":"DJ Bradley","year":"1989","unstructured":"Bradley DJ, Young WS 3rd, Weinberger C. Differential expression of alpha and beta thyroid hormone receptor genes in rat brain and pituitary. Proc Natl Acad Sci U S A. 1989;86(18):7250\u20134.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"11","key":"962_CR80","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.1089\/105072503770867228","volume":"13","author":"I Jones","year":"2003","unstructured":"Jones I, et al. The thyroid hormone receptor beta gene: structure and functions in the brain and sensory systems. Thyroid. 2003;13(11):1057\u201368.","journal-title":"Thyroid"},{"issue":"1\u20132","key":"962_CR81","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.mce.2008.03.006","volume":"287","author":"J Nunez","year":"2008","unstructured":"Nunez J, et al. Multigenic control of thyroid hormone functions in the nervous system. Mol Cell Endocrinol. 2008;287(1\u20132):1\u201312.","journal-title":"Mol Cell Endocrinol"},{"issue":"10","key":"962_CR82","doi-asserted-by":"publisher","first-page":"1904","DOI":"10.1210\/me.2010-0175","volume":"24","author":"K Wallis","year":"2010","unstructured":"Wallis K, et al. The thyroid hormone receptor alpha1 protein is expressed in embryonic postmitotic neurons and persists in most adult neurons. Mol Endocrinol. 2010;24(10):1904\u201316.","journal-title":"Mol Endocrinol"},{"issue":"6","key":"962_CR83","doi-asserted-by":"publisher","first-page":"2288","DOI":"10.1523\/JNEUROSCI.12-06-02288.1992","volume":"12","author":"DJ Bradley","year":"1992","unstructured":"Bradley DJ, Towle HC, Young WS 3rd. Spatial and temporal expression of alpha- and beta-thyroid hormone receptor mRNAs, including the beta 2-subtype, in the developing mammalian nervous system. J Neurosci. 1992;12(6):2288\u2013302.","journal-title":"J Neurosci"},{"issue":"5","key":"962_CR84","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1210\/er.2003-0033","volume":"26","author":"GJ Kahaly","year":"2005","unstructured":"Kahaly GJ, Dillmann WH. Thyroid hormone action in the heart. Endocr Rev. 2005;26(5):704\u201328.","journal-title":"Endocr Rev"},{"issue":"2","key":"962_CR85","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1152\/physrev.00009.2005","volume":"86","author":"JE Silva","year":"2006","unstructured":"Silva JE. Thermogenic mechanisms and their hormonal regulation. Physiol Rev. 2006;86(2):435\u201364.","journal-title":"Physiol Rev"},{"issue":"4","key":"962_CR86","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1016\/j.tem.2009.11.008","volume":"21","author":"E Fliers","year":"2010","unstructured":"Fliers E, Klieverik LP, Kalsbeek A. Novel neural pathways for metabolic effects of thyroid hormone. Trends Endocrinol Metab. 2010;21(4):230\u20136.","journal-title":"Trends Endocrinol Metab"},{"issue":"9","key":"962_CR87","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1038\/nm.2207","volume":"16","author":"M Lopez","year":"2010","unstructured":"Lopez M, et al. Hypothalamic AMPK and fatty acid metabolism mediate thyroid regulation of energy balance. Nat Med. 2010;16(9):1001\u20138.","journal-title":"Nat Med"},{"issue":"5","key":"962_CR88","doi-asserted-by":"publisher","first-page":"2388","DOI":"10.1210\/en.2009-1201","volume":"151","author":"J Mittag","year":"2010","unstructured":"Mittag J, et al. Adaptations of the autonomous nervous system controlling heart rate are impaired by a mutant thyroid hormone receptor-alpha1. Endocrinology. 2010;151(5):2388\u201395.","journal-title":"Endocrinology"},{"issue":"6151","key":"962_CR89","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1038\/331091a0","volume":"331","author":"V Giguere","year":"1988","unstructured":"Giguere V, et al. Identification of a new class of steroid hormone receptors. Nature. 1988;331(6151):91\u20134.","journal-title":"Nature"},{"issue":"3","key":"962_CR90","first-page":"382","volume":"14","author":"DJ Heard","year":"2000","unstructured":"Heard DJ, et al. Human ERRgamma, a third member of the estrogen receptor-related receptor (ERR) subfamily of orphan nuclear receptors: tissue-specific isoforms are expressed during development and in the adult. Mol Endocrinol. 2000;14(3):382\u201392.","journal-title":"Mol Endocrinol"},{"issue":"32","key":"962_CR91","doi-asserted-by":"publisher","first-page":"22618","DOI":"10.1074\/jbc.274.32.22618","volume":"274","author":"H Hong","year":"1999","unstructured":"Hong H, Yang L, Stallcup MR. Hormone-independent transcriptional activation and coactivator binding by novel orphan nuclear receptor ERR3. J Biol Chem. 1999;274(32):22618\u201326.","journal-title":"J Biol Chem"},{"issue":"7","key":"962_CR92","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1172\/JCI10268","volume":"106","author":"JJ Lehman","year":"2000","unstructured":"Lehman JJ, et al. Peroxisome proliferator-activated receptor gamma coactivator-1 promotes cardiac mitochondrial biogenesis. J Clin Invest. 2000;106(7):847\u201356.","journal-title":"J Clin Invest"},{"issue":"14","key":"962_CR93","doi-asserted-by":"publisher","first-page":"1948","DOI":"10.1101\/gad.1661708","volume":"22","author":"L Lai","year":"2008","unstructured":"Lai L, et al. Transcriptional coactivators PGC-1alpha and PGC-lbeta control overlapping programs required for perinatal maturation of the heart. Genes Dev. 2008;22(14):1948\u201361.","journal-title":"Genes Dev"},{"issue":"1","key":"962_CR94","doi-asserted-by":"publisher","first-page":"H185","DOI":"10.1152\/ajpheart.00081.2008","volume":"295","author":"JJ Lehman","year":"2008","unstructured":"Lehman JJ, et al. The transcriptional coactivator PGC-1alpha is essential for maximal and efficient cardiac mitochondrial fatty acid oxidation and lipid homeostasis. Am J Physiol Heart Circ Physiol. 2008;295(1):H185\u201396.","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"20","key":"962_CR95","doi-asserted-by":"publisher","first-page":"9079","DOI":"10.1128\/MCB.24.20.9079-9091.2004","volume":"24","author":"JM Huss","year":"2004","unstructured":"Huss JM, et al. Estrogen-related receptor alpha directs peroxisome proliferator-activated receptor alpha signaling in the transcriptional control of energy metabolism in cardiac and skeletal muscle. Mol Cell Biol. 2004;24(20):9079\u201391.","journal-title":"Mol Cell Biol"},{"key":"962_CR96","doi-asserted-by":"publisher","DOI":"10.3390\/cells9081765","author":"F Ghanbari","year":"2020","unstructured":"Ghanbari F, Mader S, Philip A. Cholesterol as an endogenous ligand of ERRalpha promotes ERRalpha-mediated cellular proliferation and metabolic target gene expression in breast cancer cells. Cells. 2020. https:\/\/doi.org\/10.3390\/cells9081765.","journal-title":"Cells"},{"issue":"12","key":"962_CR97","doi-asserted-by":"publisher","first-page":"1685","DOI":"10.1161\/CIRCRESAHA.119.316100","volume":"126","author":"T Sakamoto","year":"2020","unstructured":"Sakamoto T, et al. A critical role for estrogen-related receptor signaling in cardiac maturation. Circ Res. 2020;126(12):1685\u2013702.","journal-title":"Circ Res"},{"issue":"1","key":"962_CR98","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.cmet.2007.06.005","volume":"6","author":"JM Huss","year":"2007","unstructured":"Huss JM, et al. The nuclear receptor ERRalpha is required for the bioenergetic and functional adaptation to cardiac pressure overload. Cell Metab. 2007;6(1):25\u201337.","journal-title":"Cell Metab"},{"issue":"17","key":"962_CR99","doi-asserted-by":"publisher","first-page":"6570","DOI":"10.1073\/pnas.0401401101","volume":"101","author":"VK Mootha","year":"2004","unstructured":"Mootha VK, et al. Erralpha and Gabpa\/b specify PGC-1alpha-dependent oxidative phosphorylation gene expression that is altered in diabetic muscle. Proc Natl Acad Sci U S A. 2004;101(17):6570\u20135.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"17","key":"962_CR100","doi-asserted-by":"publisher","first-page":"6472","DOI":"10.1073\/pnas.0308686101","volume":"101","author":"SN Schreiber","year":"2004","unstructured":"Schreiber SN, et al. The estrogen-related receptor alpha (ERRalpha) functions in PPARgamma coactivator 1alpha (PGC-1alpha)-induced mitochondrial biogenesis. Proc Natl Acad Sci U S A. 2004;101(17):6472\u20137.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"962_CR101","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.cmet.2007.06.007","volume":"6","author":"WA Alaynick","year":"2007","unstructured":"Alaynick WA, et al. ERRgamma directs and maintains the transition to oxidative metabolism in the postnatal heart. Cell Metab. 2007;6(1):13\u201324.","journal-title":"Cell Metab"},{"issue":"2","key":"962_CR102","first-page":"46","volume":"6","author":"KF Cunningham","year":"2016","unstructured":"Cunningham KF, et al. Increased expression of estrogen-related receptor beta during adaptation of adult cardiomyocytes to sustained hypoxia. Am J Cardiovasc Dis. 2016;6(2):46\u201354.","journal-title":"Am J Cardiovasc Dis"},{"issue":"9","key":"962_CR103","doi-asserted-by":"publisher","first-page":"1912","DOI":"10.1016\/j.bbadis.2015.06.016","volume":"1852","author":"JM Huss","year":"2015","unstructured":"Huss JM, Garbacz WG, Xie W. Constitutive activities of estrogen-related receptors: transcriptional regulation of metabolism by the ERR pathways in health and disease. Biochim Biophys Acta. 2015;1852(9):1912\u201327.","journal-title":"Biochim Biophys Acta"},{"issue":"3","key":"962_CR104","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1016\/j.celrep.2015.03.032","volume":"11","author":"H Cui","year":"2015","unstructured":"Cui H, et al. Behavioral disturbances in estrogen-related receptor alpha-null mice. Cell Rep. 2015;11(3):344\u201350.","journal-title":"Cell Rep"},{"issue":"2","key":"962_CR105","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1016\/S0169-328X(00)00063-2","volume":"77","author":"DE Lorke","year":"2000","unstructured":"Lorke DE, et al. Differential expression of the estrogen receptor-related receptor gamma in the mouse brain. Brain Res Mol Brain Res. 2000;77(2):277\u201380.","journal-title":"Brain Res Mol Brain Res"},{"key":"962_CR106","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/1472-6793-13-10","volume":"13","author":"MS Byerly","year":"2013","unstructured":"Byerly MS, et al. Estrogen-related receptor beta deficiency alters body composition and response to restraint stress. BMC Physiol. 2013;13:10.","journal-title":"BMC Physiol"},{"issue":"3","key":"962_CR107","doi-asserted-by":"publisher","first-page":"R47","DOI":"10.1530\/JOE-12-0582","volume":"217","author":"DM Kelly","year":"2013","unstructured":"Kelly DM, Jones TH. Testosterone: a vascular hormone in health and disease. J Endocrinol. 2013;217(3):R47-71.","journal-title":"J Endocrinol"},{"issue":"16","key":"962_CR108","doi-asserted-by":"publisher","first-page":"1674","DOI":"10.1016\/j.jacc.2011.07.019","volume":"58","author":"C Ohlsson","year":"2011","unstructured":"Ohlsson C, et al. High serum testosterone is associated with reduced risk of cardiovascular events in elderly men. The MrOS (Osteoporotic Fractures in Men) study in Sweden. J Am Coll Cardiol. 2011;58(16):1674\u201381.","journal-title":"J Am Coll Cardiol"},{"issue":"10","key":"962_CR109","doi-asserted-by":"publisher","first-page":"3007","DOI":"10.1210\/jc.2011-1137","volume":"96","author":"AB Araujo","year":"2011","unstructured":"Araujo AB, et al. Clinical review: endogenous testosterone and mortality in men: a systematic review and meta-analysis. J Clin Endocrinol Metab. 2011;96(10):3007\u201319.","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"962_CR110","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1016\/j.cardfail.2008.12.011","volume":"15","author":"EA Jankowska","year":"2009","unstructured":"Jankowska EA, et al. Reduction in circulating testosterone relates to exercise capacity in men with chronic heart failure. J Card Fail. 2009;15(5):442\u201350.","journal-title":"J Card Fail"},{"issue":"10","key":"962_CR111","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1016\/S0195-668X(03)00083-6","volume":"24","author":"PJ Pugh","year":"2003","unstructured":"Pugh PJ, Jones TH, Channer KS. Acute haemodynamic effects of testosterone in men with chronic heart failure. Eur Heart J. 2003;24(10):909\u201315.","journal-title":"Eur Heart J"},{"issue":"7","key":"962_CR112","doi-asserted-by":"publisher","first-page":"3313","DOI":"10.1210\/jc.2003-031069","volume":"89","author":"CJ Malkin","year":"2004","unstructured":"Malkin CJ, et al. The effect of testosterone replacement on endogenous inflammatory cytokines and lipid profiles in hypogonadal men. J Clin Endocrinol Metab. 2004;89(7):3313\u20138.","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"962_CR113","first-page":"3","volume":"37","author":"RA Davey","year":"2016","unstructured":"Davey RA, Grossmann M. Androgen receptor structure, function and biology: from bench to bedside. Clin Biochem Rev. 2016;37(1):3\u201315.","journal-title":"Clin Biochem Rev"},{"issue":"33","key":"962_CR114","doi-asserted-by":"publisher","first-page":"29661","DOI":"10.1074\/jbc.M411694200","volume":"280","author":"Y Ikeda","year":"2005","unstructured":"Ikeda Y, et al. Androgen receptor gene knockout male mice exhibit impaired cardiac growth and exacerbation of angiotensin II-induced cardiac fibrosis. J Biol Chem. 2005;280(33):29661\u20136.","journal-title":"J Biol Chem"},{"issue":"11","key":"962_CR115","doi-asserted-by":"publisher","first-page":"5428","DOI":"10.1210\/en.2010-0663","volume":"151","author":"J Bourghardt","year":"2010","unstructured":"Bourghardt J, et al. Androgen receptor-dependent and independent atheroprotection by testosterone in male mice. Endocrinology. 2010;151(11):5428\u201337.","journal-title":"Endocrinology"},{"issue":"6","key":"962_CR116","doi-asserted-by":"publisher","first-page":"3187","DOI":"10.1210\/endo-129-6-3187","volume":"129","author":"GS Prins","year":"1991","unstructured":"Prins GS, Birch L, Greene GL. Androgen receptor localization in different cell types of the adult rat prostate. Endocrinology. 1991;129(6):3187\u201399.","journal-title":"Endocrinology"},{"issue":"4","key":"962_CR117","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1016\/S0306-4530(02)00036-7","volume":"28","author":"A Fernandez-Guasti","year":"2003","unstructured":"Fernandez-Guasti A, Swaab D, Rodriguez-Manzo G. Sexual behavior reduces hypothalamic androgen receptor immunoreactivity. Psychoneuroendocrinology. 2003;28(4):501\u201312.","journal-title":"Psychoneuroendocrinology"},{"issue":"14","key":"962_CR118","doi-asserted-by":"publisher","first-page":"4461","DOI":"10.1523\/JNEUROSCI.0296-09.2009","volume":"29","author":"K Raskin","year":"2009","unstructured":"Raskin K, et al. Conditional inactivation of androgen receptor gene in the nervous system: effects on male behavioral and neuroendocrine responses. J Neurosci. 2009;29(14):4461\u201370.","journal-title":"J Neurosci"},{"issue":"2","key":"962_CR119","doi-asserted-by":"publisher","first-page":"411","DOI":"10.2337\/db12-0135","volume":"62","author":"IC Yu","year":"2013","unstructured":"Yu IC, et al. Neuronal androgen receptor regulates insulin sensitivity via suppression of hypothalamic NF-kappaB-mediated PTP1B expression. Diabetes. 2013;62(2):411\u201323.","journal-title":"Diabetes"},{"issue":"4","key":"962_CR120","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1159\/000487762","volume":"106","author":"KA Walters","year":"2018","unstructured":"Walters KA, et al. The role of central androgen receptor actions in regulating the hypothalamic-pituitary-ovarian axis. Neuroendocrinology. 2018;106(4):389\u2013400.","journal-title":"Neuroendocrinology"},{"issue":"2","key":"962_CR121","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1002\/cphy.c150015","volume":"6","author":"JP Herman","year":"2016","unstructured":"Herman JP, et al. Regulation of the hypothalamic-pituitary-adrenocortical stress response. Compr Physiol. 2016;6(2):603\u201321.","journal-title":"Compr Physiol"},{"issue":"11","key":"962_CR122","first-page":"5118","volume":"86","author":"CE Gomez-Sanchez","year":"2001","unstructured":"Gomez-Sanchez CE, Gomez-Sanchez EP. Editorial: cardiac steroidogenesis\u2014new sites of synthesis, or much ado about nothing? J Clin Endocrinol Metab. 2001;86(11):5118\u201320.","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"962_CR123","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1007\/s00424-012-1155-2","volume":"464","author":"SR Lee","year":"2012","unstructured":"Lee SR, et al. Non-genomic effect of glucocorticoids on cardiovascular system. Pflugers Arch. 2012;464(6):549\u201359.","journal-title":"Pflugers Arch"},{"issue":"1","key":"962_CR124","doi-asserted-by":"publisher","first-page":"E11","DOI":"10.1152\/ajpendo.00100.2011","volume":"301","author":"MD Taves","year":"2011","unstructured":"Taves MD, Gomez-Sanchez CE, Soma KK. Extra-adrenal glucocorticoids and mineralocorticoids: evidence for local synthesis, regulation, and function. Am J Physiol Endocrinol Metab. 2011;301(1):E11-24.","journal-title":"Am J Physiol Endocrinol Metab"},{"issue":"32","key":"962_CR125","doi-asserted-by":"publisher","first-page":"3574","DOI":"10.2174\/138161210793797870","volume":"16","author":"U Nussinovitch","year":"2010","unstructured":"Nussinovitch U, et al. Glucocorticoids and the cardiovascular system: state of the art. Curr Pharm Des. 2010;16(32):3574\u201385.","journal-title":"Curr Pharm Des"},{"key":"962_CR126","doi-asserted-by":"publisher","DOI":"10.3390\/cells8101227","author":"B Liu","year":"2019","unstructured":"Liu B, et al. The glucocorticoid receptor in cardiovascular health and disease. Cells. 2019. https:\/\/doi.org\/10.3390\/cells8101227.","journal-title":"Cells"},{"issue":"6","key":"962_CR127","doi-asserted-by":"publisher","first-page":"1662","DOI":"10.1016\/j.neurobiolaging.2012.11.019","volume":"34","author":"Q Wang","year":"2013","unstructured":"Wang Q, et al. Glucocorticoid receptor protein expression in human hippocampus; stability with age. Neurobiol Aging. 2013;34(6):1662\u201373.","journal-title":"Neurobiol Aging"},{"key":"962_CR128","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1016\/j.psyneuen.2014.03.018","volume":"45","author":"S Ghosal","year":"2014","unstructured":"Ghosal S, et al. Glucocorticoid receptors in the nucleus of the solitary tract (NTS) decrease endocrine and behavioral stress responses. Psychoneuroendocrinology. 2014;45:142\u201353.","journal-title":"Psychoneuroendocrinology"},{"issue":"4","key":"962_CR129","doi-asserted-by":"publisher","first-page":"383","DOI":"10.31887\/DCNS.2006.8.4\/ssmith","volume":"8","author":"SM Smith","year":"2006","unstructured":"Smith SM, Vale WW. The role of the hypothalamic-pituitary-adrenal axis in neuroendocrine responses to stress. Dialogues Clin Neurosci. 2006;8(4):383\u201395.","journal-title":"Dialogues Clin Neurosci"},{"issue":"1","key":"962_CR130","doi-asserted-by":"publisher","first-page":"3250","DOI":"10.1038\/s41598-019-39867-y","volume":"9","author":"AL Gannon","year":"2019","unstructured":"Gannon AL, et al. Ablation of glucocorticoid receptor in the hindbrain of the mouse provides a novel model to investigate stress disorders. Sci Rep. 2019;9(1):3250.","journal-title":"Sci Rep"},{"issue":"3","key":"962_CR131","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1172\/JCI27958","volume":"116","author":"L Michalik","year":"2006","unstructured":"Michalik L, Wahli W. Involvement of PPAR nuclear receptors in tissue injury and wound repair. J Clin Invest. 2006;116(3):598\u2013606.","journal-title":"J Clin Invest"},{"key":"962_CR132","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21062061","author":"Y Wang","year":"2020","unstructured":"Wang Y, et al. PPARs as metabolic regulators in the liver: lessons from liver-specific PPAR-null mice. Int J Mol Sci. 2020. https:\/\/doi.org\/10.3390\/ijms21062061.","journal-title":"Int J Mol Sci"},{"key":"962_CR133","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/1475-2891-13-17","volume":"13","author":"B Grygiel-Gorniak","year":"2014","unstructured":"Grygiel-Gorniak B. Peroxisome proliferator-activated receptors and their ligands: nutritional and clinical implications\u2014a review. Nutr J. 2014;13:17.","journal-title":"Nutr J"},{"key":"962_CR134","doi-asserted-by":"publisher","DOI":"10.1155\/2008\/780452","volume":"2008","author":"MG Hall","year":"2008","unstructured":"Hall MG, Quignodon L, Desvergne B. Peroxisome proliferator-activated receptor beta\/delta in the brain: facts and hypothesis. PPAR Res. 2008;2008: 780452.","journal-title":"PPAR Res"},{"issue":"2","key":"962_CR135","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1016\/j.cell.2007.09.012","volume":"131","author":"F Gofflot","year":"2007","unstructured":"Gofflot F, et al. Systematic gene expression mapping clusters nuclear receptors according to their function in the brain. Cell. 2007;131(2):405\u201318.","journal-title":"Cell"},{"key":"962_CR136","doi-asserted-by":"publisher","first-page":"27618","DOI":"10.1038\/srep27618","volume":"6","author":"A Warden","year":"2016","unstructured":"Warden A, et al. Localization of PPAR isotypes in the adult mouse and human brain. Sci Rep. 2016;6:27618.","journal-title":"Sci Rep"},{"issue":"1","key":"962_CR137","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.neuroscience.2003.08.064","volume":"123","author":"S Moreno","year":"2004","unstructured":"Moreno S, Farioli-Vecchioli S, Ceru MP. Immunolocalization of peroxisome proliferator-activated receptors and retinoid X receptors in the adult rat CNS. Neuroscience. 2004;123(1):131\u201345.","journal-title":"Neuroscience"},{"issue":"1\u20132","key":"962_CR138","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/S0006-8993(03)02515-0","volume":"975","author":"JW Woods","year":"2003","unstructured":"Woods JW, et al. Localization of PPARdelta in murine central nervous system: expression in oligodendrocytes and neurons. Brain Res. 2003;975(1\u20132):10\u201321.","journal-title":"Brain Res"},{"issue":"4","key":"962_CR139","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.1021\/bi048032c","volume":"44","author":"SH Sheu","year":"2005","unstructured":"Sheu SH, et al. Exploring the binding site structure of the PPAR gamma ligand-binding domain by computational solvent mapping. Biochemistry. 2005;44(4):1193\u2013209.","journal-title":"Biochemistry"},{"issue":"2","key":"962_CR140","doi-asserted-by":"publisher","first-page":"E395","DOI":"10.1152\/ajpendo.00414.2001","volume":"282","author":"S Neschen","year":"2002","unstructured":"Neschen S, et al. Contrasting effects of fish oil and safflower oil on hepatic peroxisomal and tissue lipid content. Am J Physiol Endocrinol Metab. 2002;282(2):E395-401.","journal-title":"Am J Physiol Endocrinol Metab"},{"issue":"3","key":"962_CR141","first-page":"441","volume":"19","author":"AP Jain","year":"2015","unstructured":"Jain AP, Aggarwal KK, Zhang PY. Omega-3 fatty acids and cardiovascular disease. Eur Rev Med Pharmacol Sci. 2015;19(3):441\u20135.","journal-title":"Eur Rev Med Pharmacol Sci"},{"issue":"10","key":"962_CR142","doi-asserted-by":"publisher","first-page":"1569","DOI":"10.1016\/j.bbalip.2016.01.019","volume":"1861","author":"X Palomer","year":"2016","unstructured":"Palomer X, et al. PPARbeta\/delta and lipid metabolism in the heart. Biochim Biophys Acta. 2016;1861(10):1569\u201378.","journal-title":"Biochim Biophys Acta"},{"issue":"5","key":"962_CR143","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1111\/j.1463-1326.2011.01371.x","volume":"13","author":"RA Ngala","year":"2011","unstructured":"Ngala RA, et al. A new, highly selective murine peroxisome proliferator-activated receptor delta agonist increases responsiveness to thermogenic stimuli and glucose uptake in skeletal muscle in obese mice. Diabetes Obes Metab. 2011;13(5):455\u201364.","journal-title":"Diabetes Obes Metab"},{"issue":"1","key":"962_CR144","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1093\/cvr\/cvn172","volume":"80","author":"BC Yu","year":"2008","unstructured":"Yu BC, et al. Decrease of peroxisome proliferator-activated receptor delta expression in cardiomyopathy of streptozotocin-induced diabetic rats. Cardiovasc Res. 2008;80(1):78\u201387.","journal-title":"Cardiovasc Res"},{"issue":"12","key":"962_CR145","first-page":"3930","volume":"117","author":"EM Burkart","year":"2007","unstructured":"Burkart EM, et al. Nuclear receptors PPARbeta\/delta and PPARalpha direct distinct metabolic regulatory programs in the mouse heart. J Clin Invest. 2007;117(12):3930\u20139.","journal-title":"J Clin Invest"},{"key":"962_CR146","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/S0083-6729(03)01005-7","volume":"66","author":"YE Chen","year":"2003","unstructured":"Chen YE, et al. Peroxisome proliferator-activated receptors and the cardiovascular system. Vitam Horm. 2003;66:157\u201388.","journal-title":"Vitam Horm"},{"issue":"9","key":"962_CR147","doi-asserted-by":"publisher","first-page":"1168","DOI":"10.1161\/01.RES.0000127122.22685.0A","volume":"94","author":"N Marx","year":"2004","unstructured":"Marx N, et al. Peroxisome proliferator-activated receptors and atherogenesis: regulators of gene expression in vascular cells. Circ Res. 2004;94(9):1168\u201378.","journal-title":"Circ Res"},{"issue":"1","key":"962_CR148","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.vph.2005.11.014","volume":"45","author":"RM Touyz","year":"2006","unstructured":"Touyz RM, Schiffrin EL. Peroxisome proliferator-activated receptors in vascular biology-molecular mechanisms and clinical implications. Vascul Pharmacol. 2006;45(1):19\u201328.","journal-title":"Vascul Pharmacol"},{"key":"962_CR149","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1146\/annurev.biochem.77.061307.091829","volume":"77","author":"P Tontonoz","year":"2008","unstructured":"Tontonoz P, Spiegelman BM. Fat and beyond: the diverse biology of PPARgamma. Annu Rev Biochem. 2008;77:289\u2013312.","journal-title":"Annu Rev Biochem"},{"issue":"9","key":"962_CR150","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1038\/nm.2421","volume":"17","author":"S Diano","year":"2011","unstructured":"Diano S, et al. Peroxisome proliferation-associated control of reactive oxygen species sets melanocortin tone and feeding in diet-induced obesity. Nat Med. 2011;17(9):1121\u20137.","journal-title":"Nat Med"},{"issue":"2","key":"962_CR151","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1210\/en.2008-0899","volume":"150","author":"DA Sarruf","year":"2009","unstructured":"Sarruf DA, et al. Expression of peroxisome proliferator-activated receptor-gamma in key neuronal subsets regulating glucose metabolism and energy homeostasis. Endocrinology. 2009;150(2):707\u201312.","journal-title":"Endocrinology"},{"issue":"5","key":"962_CR152","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1038\/nm.2332","volume":"17","author":"M Lu","year":"2011","unstructured":"Lu M, et al. Brain PPAR-gamma promotes obesity and is required for the insulin-sensitizing effect of thiazolidinediones. Nat Med. 2011;17(5):618\u201322.","journal-title":"Nat Med"},{"issue":"6","key":"962_CR153","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1016\/j.steroids.2013.01.003","volume":"78","author":"P Thomas","year":"2013","unstructured":"Thomas P, Pang Y. Protective actions of progesterone in the cardiovascular system: potential role of membrane progesterone receptors (mPRs) in mediating rapid effects. Steroids. 2013;78(6):583\u20138.","journal-title":"Steroids"},{"issue":"4","key":"962_CR154","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1172\/JCI200111374","volume":"108","author":"RH Karas","year":"2001","unstructured":"Karas RH, et al. A complex role for the progesterone receptor in the response to vascular injury. J Clin Invest. 2001;108(4):611\u20138.","journal-title":"J Clin Invest"},{"issue":"9","key":"962_CR155","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1038\/nm0997-1005","volume":"3","author":"WS Lee","year":"1997","unstructured":"Lee WS, et al. Progesterone inhibits arterial smooth muscle cell proliferation. Nat Med. 1997;3(9):1005\u20138.","journal-title":"Nat Med"},{"issue":"5","key":"962_CR156","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1161\/01.RES.50.5.610","volume":"50","author":"AL Lin","year":"1982","unstructured":"Lin AL, McGill HC, Shain SA. Hormone receptors of the baboon cardiovascular system. Biochemical characterization of aortic and myocardial cytoplasmic progesterone receptors. Circ Res. 1982;50(5):610\u20136. https:\/\/doi.org\/10.1161\/01.RES.50.5.610.","journal-title":"Circ Res"},{"issue":"5","key":"962_CR157","doi-asserted-by":"publisher","first-page":"2237","DOI":"10.1073\/pnas.0436133100","volume":"100","author":"Y Zhu","year":"2003","unstructured":"Zhu Y, Bond J, Thomas P. Identification, classification, and partial characterization of genes in humans and other vertebrates homologous to a fish membrane progestin receptor. Proc Natl Acad Sci U S A. 2003;100(5):2237\u201342.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"962_CR158","doi-asserted-by":"publisher","first-page":"5168","DOI":"10.1038\/s41598-017-05423-9","volume":"7","author":"M Kasubuchi","year":"2017","unstructured":"Kasubuchi M, et al. Membrane progesterone receptor beta (mPRbeta\/Paqr8) promotes progesterone-dependent neurite outgrowth in PC12 neuronal cells via non-G protein-coupled receptor (GPCR) signaling. Sci Rep. 2017;7(1):5168.","journal-title":"Sci Rep"},{"key":"962_CR159","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1186\/1477-7827-7-89","volume":"7","author":"M Nutu","year":"2009","unstructured":"Nutu M, et al. Distribution and hormonal regulation of membrane progesterone receptors beta and gamma in ciliated epithelial cells of mouse and human fallopian tubes. Reprod Biol Endocrinol. 2009;7:89.","journal-title":"Reprod Biol Endocrinol"},{"issue":"12","key":"962_CR160","doi-asserted-by":"publisher","first-page":"5522","DOI":"10.1210\/en.2005-0759","volume":"146","author":"Z Cai","year":"2005","unstructured":"Cai Z, Stocco C. Expression and regulation of progestin membrane receptors in the rat corpus luteum. Endocrinology. 2005;146(12):5522\u201332.","journal-title":"Endocrinology"},{"issue":"1","key":"962_CR161","doi-asserted-by":"publisher","first-page":"8096","DOI":"10.1038\/s41598-017-08805-1","volume":"7","author":"W He","year":"2017","unstructured":"He W, et al. Hypothalamic effects of progesterone on regulation of the pulsatile and surge release of luteinising hormone in female rats. Sci Rep. 2017;7(1):8096.","journal-title":"Sci Rep"},{"issue":"7","key":"962_CR162","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0159534","volume":"11","author":"A Gal","year":"2016","unstructured":"Gal A, et al. Loss of fertility in the absence of progesterone receptor expression in Kisspeptin neurons of female mice. PLoS ONE. 2016;11(7): e0159534.","journal-title":"PLoS ONE"},{"issue":"9","key":"962_CR163","doi-asserted-by":"publisher","first-page":"3091","DOI":"10.1210\/en.2015-1300","volume":"156","author":"SB Stephens","year":"2015","unstructured":"Stephens SB, et al. Absent progesterone signaling in kisspeptin neurons disrupts the LH surge and impairs fertility in female mice. Endocrinology. 2015;156(9):3091\u20137.","journal-title":"Endocrinology"},{"issue":"3 Pt B","key":"962_CR164","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1016\/j.scr.2014.04.007","volume":"13","author":"M Masters","year":"2014","unstructured":"Masters M, Riley PR. The epicardium signals the way towards heart regeneration. Stem Cell Res. 2014;13(3 Pt B):683\u201392.","journal-title":"Stem Cell Res"},{"key":"962_CR165","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.mod.2016.12.002","volume":"143","author":"S Stefanovic","year":"2017","unstructured":"Stefanovic S, Zaffran S. Mechanisms of retinoic acid signaling during cardiogenesis. Mech Dev. 2017;143:9\u201319.","journal-title":"Mech Dev"},{"issue":"8","key":"962_CR166","doi-asserted-by":"publisher","first-page":"976","DOI":"10.1002\/dvdy.24639","volume":"247","author":"S Wang","year":"2018","unstructured":"Wang S, et al. Alterations in retinoic acid signaling affect the development of the mouse coronary vasculature. Dev Dyn. 2018;247(8):976\u201391.","journal-title":"Dev Dyn"},{"issue":"4","key":"962_CR167","doi-asserted-by":"publisher","first-page":"1449","DOI":"10.1159\/000481876","volume":"43","author":"RAC Silva","year":"2017","unstructured":"Silva RAC, et al. Cardiac remodeling induced by all-trans retinoic acid is detrimental in normal rats. Cell Physiol Biochem. 2017;43(4):1449\u201359.","journal-title":"Cell Physiol Biochem"},{"issue":"1","key":"962_CR168","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1073\/pnas.90.1.30","volume":"90","author":"G Allenby","year":"1993","unstructured":"Allenby G, et al. Retinoic acid receptors and retinoid X receptors: interactions with endogenous retinoic acids. Proc Natl Acad Sci U S A. 1993;90(1):30\u20134.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"3","key":"962_CR169","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1101\/gad.6.3.329","volume":"6","author":"DJ Mangelsdorf","year":"1992","unstructured":"Mangelsdorf DJ, et al. Characterization of three RXR genes that mediate the action of 9-cis retinoic acid. Genes Dev. 1992;6(3):329\u201344.","journal-title":"Genes Dev"},{"issue":"5","key":"962_CR170","doi-asserted-by":"publisher","first-page":"1292","DOI":"10.1002\/jcp.22457","volume":"226","author":"RS Guleria","year":"2011","unstructured":"Guleria RS, et al. Retinoic acid receptor-mediated signaling protects cardiomyocytes from hyperglycemia induced apoptosis: role of the renin-angiotensin system. J Cell Physiol. 2011;226(5):1292\u2013307.","journal-title":"J Cell Physiol"},{"issue":"2","key":"962_CR171","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1124\/jpet.118.250605","volume":"366","author":"A Marino","year":"2018","unstructured":"Marino A, et al. A retinoic acid beta2-receptor agonist exerts cardioprotective effects. J Pharmacol Exp Ther. 2018;366(2):314\u201321.","journal-title":"J Pharmacol Exp Ther"},{"issue":"2","key":"962_CR172","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1124\/jpet.121.000806","volume":"379","author":"XH Tang","year":"2021","unstructured":"Tang XH, et al. A retinoic acid receptor beta 2 agonist improves cardiac function in a heart failure model. J Pharmacol Exp Ther. 2021;379(2):182\u201390.","journal-title":"J Pharmacol Exp Ther"},{"key":"962_CR173","doi-asserted-by":"crossref","unstructured":"Watanabe, M. and H. Kakuta, Retinoid X Receptor Antagonists. Int J Mol Sci, 2018. 19(8).","DOI":"10.3390\/ijms19082354"},{"issue":"11","key":"962_CR174","doi-asserted-by":"publisher","first-page":"4272","DOI":"10.1073\/pnas.0813143106","volume":"106","author":"B Mascrez","year":"2009","unstructured":"Mascrez B, et al. A transcriptionally silent RXRalpha supports early embryonic morphogenesis and heart development. Proc Natl Acad Sci U S A. 2009;106(11):4272\u20137.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"962_CR175","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2021.111264","volume":"137","author":"M Shao","year":"2021","unstructured":"Shao M, et al. The multi-faceted role of retinoid X receptor in cardiovascular diseases. Biomed Pharmacother. 2021;137: 111264.","journal-title":"Biomed Pharmacother"},{"issue":"7\u20138","key":"962_CR176","doi-asserted-by":"publisher","DOI":"10.1002\/dvg.23303","volume":"57","author":"S Wang","year":"2019","unstructured":"Wang S, Moise AR. Recent insights on the role and regulation of retinoic acid signaling during epicardial development. Genesis. 2019;57(7\u20138): e23303.","journal-title":"Genesis"},{"issue":"10","key":"962_CR177","doi-asserted-by":"publisher","first-page":"2749","DOI":"10.1242\/dev.120.10.2749","volume":"120","author":"C Mendelsohn","year":"1994","unstructured":"Mendelsohn C, et al. Function of the retinoic acid receptors (RARs) during development (II). Multiple abnormalities at various stages of organogenesis in RAR double mutants. Development. 1994;120(10):2749\u201371.","journal-title":"Development"},{"issue":"8","key":"962_CR178","doi-asserted-by":"publisher","first-page":"1958","DOI":"10.1172\/JCI119727","volume":"100","author":"MC Colbert","year":"1997","unstructured":"Colbert MC, et al. Cardiac compartment-specific overexpression of a modified retinoic acid receptor produces dilated cardiomyopathy and congestive heart failure in transgenic mice. J Clin Invest. 1997;100(8):1958\u201368.","journal-title":"J Clin Invest"},{"issue":"3","key":"962_CR179","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1038\/s41582-020-0315-9","volume":"16","author":"H Wood","year":"2020","unstructured":"Wood H. Retinoid X receptor mediates brain clean-up after stroke. Nat Rev Neurol. 2020;16(3):128\u20139.","journal-title":"Nat Rev Neurol"},{"issue":"3","key":"962_CR180","doi-asserted-by":"publisher","first-page":"958","DOI":"10.1161\/STROKEAHA.119.027315","volume":"51","author":"SM Ting","year":"2020","unstructured":"Ting SM, et al. Brain cleanup as a potential target for poststroke recovery: the role of RXR (retinoic X receptor) in phagocytes. Stroke. 2020;51(3):958\u201366.","journal-title":"Stroke"},{"issue":"1","key":"962_CR181","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1186\/s12974-019-1432-5","volume":"16","author":"Y Zuo","year":"2019","unstructured":"Zuo Y, et al. Activation of retinoid X receptor by bexarotene attenuates neuroinflammation via PPARgamma\/SIRT6\/FoxO3a pathway after subarachnoid hemorrhage in rats. J Neuroinflamm. 2019;16(1):47.","journal-title":"J Neuroinflamm"},{"key":"962_CR182","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.cotox.2018.01.005","volume":"8","author":"AM Jetten","year":"2018","unstructured":"Jetten AM, et al. Retinoic acid-related Orphan Receptor gamma (RORgamma): connecting sterol metabolism to regulation of the immune system and autoimmune disease. Curr Opin Toxicol. 2018;8:66\u201380.","journal-title":"Curr Opin Toxicol"},{"issue":"3","key":"962_CR183","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1111\/j.1600-079X.2008.00591.x","volume":"45","author":"B Caballero","year":"2008","unstructured":"Caballero B, et al. Favorable effects of a prolonged treatment with melatonin on the level of oxidative damage and neurodegeneration in senescence-accelerated mice. J Pineal Res. 2008;45(3):302\u201311.","journal-title":"J Pineal Res"},{"issue":"10","key":"962_CR184","doi-asserted-by":"publisher","first-page":"1796","DOI":"10.1161\/ATVBAHA.108.171546","volume":"28","author":"EJ Kim","year":"2008","unstructured":"Kim EJ, et al. Transcriptional activation of HIF-1 by RORalpha and its role in hypoxia signaling. Arterioscler Thromb Vasc Biol. 2008;28(10):1796\u2013802.","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"3","key":"962_CR185","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1038\/nrd4100","volume":"13","author":"DJ Kojetin","year":"2014","unstructured":"Kojetin DJ, Burris TP. REV-ERB and ROR nuclear receptors as drug targets. Nat Rev Drug Discov. 2014;13(3):197\u2013216.","journal-title":"Nat Rev Drug Discov"},{"issue":"6","key":"962_CR186","doi-asserted-by":"publisher","first-page":"300060521101966","DOI":"10.1177\/03000605211019663","volume":"49","author":"H Meng","year":"2021","unstructured":"Meng H, et al. High retinoic acid receptor-related orphan receptor A gene expression in peripheral blood leukocytes may be related to acute myocardial infarction. J Int Med Res. 2021;49(6):3000605211019663.","journal-title":"J Int Med Res"},{"issue":"5","key":"962_CR187","first-page":"441","volume":"161","author":"H Matsuoka","year":"2017","unstructured":"Matsuoka H, et al. The retinoic acid receptor-related orphan receptor alpha positively regulates tight junction protein claudin domain-containing 1 mRNA expression in human brain endothelial cells. J Biochem. 2017;161(5):441\u201350.","journal-title":"J Biochem"},{"issue":"3","key":"962_CR188","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1016\/j.jaci.2016.11.039","volume":"140","author":"MV Singh","year":"2017","unstructured":"Singh MV, et al. Abnormal CD161(+) immune cells and retinoic acid receptor-related orphan receptor gammat-mediate enhanced IL-17F expression in the setting of genetic hypertension. J Allergy Clin Immunol. 2017;140(3):809-821 e3.","journal-title":"J Allergy Clin Immunol"},{"key":"962_CR189","doi-asserted-by":"publisher","DOI":"10.1111\/jpi.12378","author":"Y Zhao","year":"2017","unstructured":"Zhao Y, et al. Novel protective role of the circadian nuclear receptor retinoic acid-related orphan receptor-alpha in diabetic cardiomyopathy. J Pineal Res. 2017. https:\/\/doi.org\/10.1111\/jpi.12378.","journal-title":"J Pineal Res"},{"issue":"6567","key":"962_CR190","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1038\/379736a0","volume":"379","author":"BA Hamilton","year":"1996","unstructured":"Hamilton BA, et al. Disruption of the nuclear hormone receptor RORalpha in staggerer mice. Nature. 1996;379(6567):736\u20139.","journal-title":"Nature"},{"issue":"7","key":"962_CR191","doi-asserted-by":"publisher","first-page":"3960","DOI":"10.1073\/pnas.95.7.3960","volume":"95","author":"M Steinmayr","year":"1998","unstructured":"Steinmayr M, et al. staggerer phenotype in retinoid-related orphan receptor alpha-deficient mice. Proc Natl Acad Sci U S A. 1998;95(7):3960\u20135.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1\u20132","key":"962_CR192","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/S0303-7207(98)00058-6","volume":"140","author":"ML Aubert","year":"1998","unstructured":"Aubert ML, et al. Metabolic control of sexual function and growth: role of neuropeptide Y and leptin. Mol Cell Endocrinol. 1998;140(1\u20132):107\u201313.","journal-title":"Mol Cell Endocrinol"},{"key":"962_CR193","doi-asserted-by":"publisher","first-page":"1187","DOI":"10.3389\/fimmu.2018.01187","volume":"9","author":"J Fan","year":"2018","unstructured":"Fan J, et al. Retinoic acid receptor-related orphan receptors: critical roles in tumorigenesis. Front Immunol. 2018;9:1187.","journal-title":"Front Immunol"},{"issue":"9","key":"962_CR194","doi-asserted-by":"publisher","first-page":"1278","DOI":"10.1038\/s12276-021-00679-8","volume":"53","author":"JM Lee","year":"2021","unstructured":"Lee JM, Kim H, Baek SH. Unraveling the physiological roles of retinoic acid receptor-related orphan receptor alpha. Exp Mol Med. 2021;53(9):1278\u201386.","journal-title":"Exp Mol Med"},{"issue":"4","key":"962_CR195","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1016\/j.neuron.2004.07.018","volume":"43","author":"TK Sato","year":"2004","unstructured":"Sato TK, et al. A functional genomics strategy reveals Rora as a component of the mammalian circadian clock. Neuron. 2004;43(4):527\u201337.","journal-title":"Neuron"},{"issue":"11","key":"962_CR196","doi-asserted-by":"publisher","first-page":"4453","DOI":"10.1073\/pnas.0808180106","volume":"106","author":"FA Scheer","year":"2009","unstructured":"Scheer FA, et al. Adverse metabolic and cardiovascular consequences of circadian misalignment. Proc Natl Acad Sci U S A. 2009;106(11):4453\u20138.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"962_CR197","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21186483","author":"N Latic","year":"2020","unstructured":"Latic N, Erben RG. Vitamin D and cardiovascular disease, with emphasis on hypertension, atherosclerosis, and heart failure. Int J Mol Sci. 2020. https:\/\/doi.org\/10.3390\/ijms21186483.","journal-title":"Int J Mol Sci"},{"issue":"4","key":"962_CR198","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1093\/ije\/10.4.337","volume":"10","author":"R Scragg","year":"1981","unstructured":"Scragg R. Seasonality of cardiovascular disease mortality and the possible protective effect of ultra-violet radiation. Int J Epidemiol. 1981;10(4):337\u201341.","journal-title":"Int J Epidemiol"},{"issue":"2","key":"962_CR199","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1016\/j.jacc.2011.02.051","volume":"58","author":"I Al Mheid","year":"2011","unstructured":"Al Mheid I, et al. Vitamin D status is associated with arterial stiffness and vascular dysfunction in healthy humans. J Am Coll Cardiol. 2011;58(2):186\u201392.","journal-title":"J Am Coll Cardiol"},{"issue":"11","key":"962_CR200","doi-asserted-by":"publisher","first-page":"1636","DOI":"10.1016\/j.amjcard.2011.01.048","volume":"107","author":"JH Lee","year":"2011","unstructured":"Lee JH, et al. Prevalence of vitamin D deficiency in patients with acute myocardial infarction. Am J Cardiol. 2011;107(11):1636\u20138.","journal-title":"Am J Cardiol"},{"issue":"2","key":"962_CR201","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1681\/ASN.2006060573","volume":"18","author":"GM London","year":"2007","unstructured":"London GM, et al. Mineral metabolism and arterial functions in end-stage renal disease: potential role of 25-hydroxyvitamin D deficiency. J Am Soc Nephrol. 2007;18(2):613\u201320.","journal-title":"J Am Soc Nephrol"},{"issue":"2","key":"962_CR202","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1210\/jc.2011-1309","volume":"97","author":"A Avenell","year":"2012","unstructured":"Avenell A, et al. Long-term follow-up for mortality and cancer in a randomized placebo-controlled trial of vitamin D(3) and\/or calcium (RECORD trial). J Clin Endocrinol Metab. 2012;97(2):614\u201322.","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"962_CR203","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1093\/ajcn\/83.4.754","volume":"83","author":"SS Schleithoff","year":"2006","unstructured":"Schleithoff SS, et al. Vitamin D supplementation improves cytokine profiles in patients with congestive heart failure: a double-blind, randomized, placebo-controlled trial. Am J Clin Nutr. 2006;83(4):754\u20139.","journal-title":"Am J Clin Nutr"},{"issue":"4","key":"962_CR204","doi-asserted-by":"publisher","first-page":"892","DOI":"10.1172\/JCI25901","volume":"116","author":"Y Ma","year":"2006","unstructured":"Ma Y, et al. Identification and characterization of noncalcemic, tissue-selective, nonsecosteroidal vitamin D receptor modulators. J Clin Invest. 2006;116(4):892\u2013904.","journal-title":"J Clin Invest"},{"issue":"1","key":"962_CR205","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.jchemneu.2004.08.006","volume":"29","author":"DW Eyles","year":"2005","unstructured":"Eyles DW, et al. Distribution of the vitamin D receptor and 1 alpha-hydroxylase in human brain. J Chem Neuroanat. 2005;29(1):21\u201330.","journal-title":"J Chem Neuroanat"},{"issue":"2","key":"962_CR206","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/S0891-0618(99)00002-2","volume":"16","author":"K Prufer","year":"1999","unstructured":"Prufer K, et al. Distribution of 1,25-dihydroxyvitamin D3 receptor immunoreactivity in the rat brain and spinal cord. J Chem Neuroanat. 1999;16(2):135\u201345.","journal-title":"J Chem Neuroanat"},{"key":"962_CR207","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.neuroscience.2013.01.035","volume":"236","author":"X Cui","year":"2013","unstructured":"Cui X, et al. The vitamin D receptor in dopamine neurons; its presence in human substantia nigra and its ontogenesis in rat midbrain. Neuroscience. 2013;236:77\u201387.","journal-title":"Neuroscience"},{"key":"962_CR208","doi-asserted-by":"publisher","first-page":"19","DOI":"10.3389\/fneur.2020.00019","volume":"11","author":"PW Lee","year":"2020","unstructured":"Lee PW, et al. Neuron-specific vitamin D signaling attenuates microglia activation and CNS autoimmunity. Front Neurol. 2020;11:19.","journal-title":"Front Neurol"},{"issue":"2","key":"962_CR209","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1097\/NEN.0b013e31827f4fcc","volume":"72","author":"J Smolders","year":"2013","unstructured":"Smolders J, et al. Expression of vitamin D receptor and metabolizing enzymes in multiple sclerosis-affected brain tissue. J Neuropathol Exp Neurol. 2013;72(2):91\u2013105.","journal-title":"J Neuropathol Exp Neurol"},{"issue":"6315","key":"962_CR210","doi-asserted-by":"publisher","first-page":"994","DOI":"10.1126\/science.aah4965","volume":"354","author":"J Bass","year":"2016","unstructured":"Bass J, Lazar MA. Circadian time signatures of fitness and disease. Science. 2016;354(6315):994\u20139.","journal-title":"Science"},{"issue":"8","key":"962_CR211","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.1038\/nm.3213","volume":"19","author":"E Woldt","year":"2013","unstructured":"Woldt E, et al. Rev-erb-alpha modulates skeletal muscle oxidative capacity by regulating mitochondrial biogenesis and autophagy. Nat Med. 2013;19(8):1039\u201346.","journal-title":"Nat Med"},{"issue":"7396","key":"962_CR212","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1038\/nature11048","volume":"485","author":"H Cho","year":"2012","unstructured":"Cho H, et al. Regulation of circadian behaviour and metabolism by REV-ERB-alpha and REV-ERB-beta. Nature. 2012;485(7396):123\u20137.","journal-title":"Nature"},{"issue":"18","key":"962_CR213","doi-asserted-by":"publisher","first-page":"3481","DOI":"10.1093\/nar\/24.18.3481","volume":"24","author":"L Burke","year":"1996","unstructured":"Burke L, et al. Transcriptional repression by the orphan steroid receptor RVR\/Rev-erb beta is dependent on the signature motif and helix 5 in the E region: functional evidence for a biological role of RVR in myogenesis. Nucleic Acids Res. 1996;24(18):3481\u20139.","journal-title":"Nucleic Acids Res"},{"issue":"2","key":"962_CR214","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1016\/S0092-8674(02)00825-5","volume":"110","author":"N Preitner","year":"2002","unstructured":"Preitner N, et al. The orphan nuclear receptor REV-ERBalpha controls circadian transcription within the positive limb of the mammalian circadian oscillator. Cell. 2002;110(2):251\u201360.","journal-title":"Cell"},{"issue":"5857","key":"962_CR215","doi-asserted-by":"publisher","first-page":"1786","DOI":"10.1126\/science.1150179","volume":"318","author":"L Yin","year":"2007","unstructured":"Yin L, et al. Rev-erbalpha, a heme sensor that coordinates metabolic and circadian pathways. Science. 2007;318(5857):1786\u20139.","journal-title":"Science"},{"issue":"7396","key":"962_CR216","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1038\/nature11030","volume":"485","author":"LA Solt","year":"2012","unstructured":"Solt LA, et al. Regulation of circadian behaviour and metabolism by synthetic REV-ERB agonists. Nature. 2012;485(7396):62\u20138.","journal-title":"Nature"},{"issue":"7","key":"962_CR217","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1101\/gad.186858.112","volume":"26","author":"A Bugge","year":"2012","unstructured":"Bugge A, et al. Rev-erbalpha and Rev-erbbeta coordinately protect the circadian clock and normal metabolic function. Genes Dev. 2012;26(7):657\u201367.","journal-title":"Genes Dev"},{"issue":"7476","key":"962_CR218","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1038\/nature12642","volume":"503","author":"Z Gerhart-Hines","year":"2013","unstructured":"Gerhart-Hines Z, et al. The nuclear receptor Rev-erbalpha controls circadian thermogenic plasticity. Nature. 2013;503(7476):410\u20133.","journal-title":"Nature"},{"issue":"6","key":"962_CR219","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1161\/CIRCULATIONAHA.121.056076","volume":"145","author":"S Song","year":"2022","unstructured":"Song S, et al. Myocardial Rev-erb-Mediated diurnal metabolic rhythm and obesity paradox. Circulation. 2022;145(6):448\u201364.","journal-title":"Circulation"},{"issue":"3","key":"962_CR220","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1016\/j.bbrc.2015.03.070","volume":"460","author":"S Sitaula","year":"2015","unstructured":"Sitaula S, et al. Suppression of atherosclerosis by synthetic REV-ERB agonist. Biochem Biophys Res Commun. 2015;460(3):566\u201371.","journal-title":"Biochem Biophys Res Commun"},{"issue":"12","key":"962_CR221","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0189330","volume":"12","author":"EN Stujanna","year":"2017","unstructured":"Stujanna EN, et al. Rev-erb agonist improves adverse cardiac remodeling and survival in myocardial infarction through an anti-inflammatory mechanism. PLoS ONE. 2017;12(12): e0189330.","journal-title":"PLoS ONE"},{"issue":"1","key":"962_CR222","doi-asserted-by":"publisher","first-page":"1216","DOI":"10.1038\/s41467-021-21477-w","volume":"12","author":"T Zhang","year":"2021","unstructured":"Zhang T, et al. Dysregulation of REV-ERBalpha impairs GABAergic function and promotes epileptic seizures in preclinical models. Nat Commun. 2021;12(1):1216.","journal-title":"Nat Commun"},{"issue":"4","key":"962_CR223","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1210\/me.2013-1351","volume":"28","author":"J Jager","year":"2014","unstructured":"Jager J, et al. Behavioral changes and dopaminergic dysregulation in mice lacking the nuclear receptor Rev-erbalpha. Mol Endocrinol. 2014;28(4):490\u20138.","journal-title":"Mol Endocrinol"},{"issue":"4","key":"962_CR224","doi-asserted-by":"publisher","first-page":"858","DOI":"10.1016\/j.cell.2014.03.039","volume":"157","author":"S Chung","year":"2014","unstructured":"Chung S, et al. Impact of circadian nuclear receptor REV-ERBalpha on midbrain dopamine production and mood regulation. Cell. 2014;157(4):858\u201368.","journal-title":"Cell"},{"key":"962_CR225","doi-asserted-by":"publisher","DOI":"10.1172\/JCI140424","author":"M Adlanmerini","year":"2021","unstructured":"Adlanmerini M, et al. Hypothalamic REV-ERB nuclear receptors control diurnal food intake and leptin sensitivity in diet-induced obese mice. J Clin Invest. 2021. https:\/\/doi.org\/10.1172\/JCI140424.","journal-title":"J Clin Invest"},{"issue":"10","key":"962_CR226","doi-asserted-by":"publisher","first-page":"2020","DOI":"10.1161\/01.ATV.0000178994.21828.a7","volume":"25","author":"T Claudel","year":"2005","unstructured":"Claudel T, Staels B, Kuipers F. The Farnesoid X receptor: a molecular link between bile acid and lipid and glucose metabolism. Arterioscler Thromb Vasc Biol. 2005;25(10):2020\u201330.","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"24","key":"962_CR227","doi-asserted-by":"publisher","first-page":"1834","DOI":"10.1093\/eurheartj\/ehs011","volume":"34","author":"J Pu","year":"2013","unstructured":"Pu J, et al. Cardiomyocyte-expressed farnesoid-X-receptor is a novel apoptosis mediator and contributes to myocardial ischaemia\/reperfusion injury. Eur Heart J. 2013;34(24):1834\u201345.","journal-title":"Eur Heart J"},{"issue":"18","key":"962_CR228","doi-asserted-by":"publisher","first-page":"3233","DOI":"10.1002\/1873-3468.12373","volume":"590","author":"C Huang","year":"2016","unstructured":"Huang C, et al. Identification of functional farnesoid X receptors in brain neurons. FEBS Lett. 2016;590(18):3233\u201342.","journal-title":"FEBS Lett"},{"issue":"2","key":"962_CR229","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1016\/j.ajpath.2015.10.005","volume":"186","author":"M McMillin","year":"2016","unstructured":"McMillin M, et al. Bile acid signaling is involved in the neurological decline in a murine model of acute liver failure. Am J Pathol. 2016;186(2):312\u201323.","journal-title":"Am J Pathol"},{"key":"962_CR230","doi-asserted-by":"publisher","DOI":"10.3390\/molecules24101992","author":"FH Bazzari","year":"2019","unstructured":"Bazzari FH, Abdallah DM, El-Abhar HS. Chenodeoxycholic acid ameliorates AlCl3-induced Alzheimer\u2019s disease neurotoxicity and cognitive deterioration via enhanced insulin signaling in rats. Molecules. 2019. https:\/\/doi.org\/10.3390\/molecules24101992.","journal-title":"Molecules"},{"key":"962_CR231","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.steroids.2017.07.001","volume":"125","author":"T Higashi","year":"2017","unstructured":"Higashi T, et al. Unconjugated bile acids in rat brain: analytical method based on LC\/ESI-MS\/MS with chemical derivatization and estimation of their origin by comparison to serum levels. Steroids. 2017;125:107\u201313.","journal-title":"Steroids"},{"key":"962_CR232","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1016\/j.psychres.2018.04.025","volume":"264","author":"WG Chen","year":"2018","unstructured":"Chen WG, et al. Hippocampal FXR plays a role in the pathogenesis of depression: a preliminary study based on lentiviral gene modulation. Psychiatry Res. 2018;264:374\u20139.","journal-title":"Psychiatry Res"},{"key":"962_CR233","doi-asserted-by":"publisher","first-page":"9335","DOI":"10.12659\/MSM.920065","volume":"25","author":"Q Chen","year":"2019","unstructured":"Chen Q, et al. Farnesoid X receptor (FXR) aggravates amyloid-beta-triggered apoptosis by modulating the cAMP-response element-binding protein (CREB)\/brain-derived neurotrophic factor (BDNF) pathway in vitro. Med Sci Monit. 2019;25:9335\u201345.","journal-title":"Med Sci Monit"},{"issue":"9","key":"962_CR234","doi-asserted-by":"publisher","first-page":"1675","DOI":"10.1136\/gutjnl-2020-321757","volume":"70","author":"SY Zhang","year":"2021","unstructured":"Zhang SY, et al. FXR in the dorsal vagal complex is sufficient and necessary for upper small intestinal microbiome-mediated changes of TCDCA to alter insulin action in rats. Gut. 2021;70(9):1675\u201383.","journal-title":"Gut"},{"issue":"10","key":"962_CR235","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1093\/jmcb\/mjaa048","volume":"12","author":"Y Yang","year":"2020","unstructured":"Yang Y, Xu Y. The central melanocortin system and human obesity. J Mol Cell Biol. 2020;12(10):785\u201397.","journal-title":"J Mol Cell Biol"},{"key":"962_CR236","doi-asserted-by":"publisher","DOI":"10.3390\/ijms19072017","author":"S Kouidhi","year":"2018","unstructured":"Kouidhi S, Clerget-Froidevaux MS. Integrating thyroid hormone signaling in hypothalamic control of metabolism: crosstalk between nuclear receptors. Int J Mol Sci. 2018. https:\/\/doi.org\/10.3390\/ijms19072017.","journal-title":"Int J Mol Sci"},{"issue":"6","key":"962_CR237","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1016\/j.tem.2016.03.018","volume":"27","author":"R Courtney","year":"2016","unstructured":"Courtney R, Landreth GE. LXR regulation of brain cholesterol: from development to disease. Trends Endocrinol Metab. 2016;27(6):404\u201314.","journal-title":"Trends Endocrinol Metab"},{"issue":"5","key":"962_CR238","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1016\/S0959-437X(98)80013-0","volume":"8","author":"DJ Peet","year":"1998","unstructured":"Peet DJ, Janowski BA, Mangelsdorf DJ. The LXRs: a new class of oxysterol receptors. Curr Opin Genet Dev. 1998;8(5):571\u20135.","journal-title":"Curr Opin Genet Dev"},{"issue":"1","key":"962_CR239","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/s00395-015-0520-7","volume":"111","author":"MV Cannon","year":"2016","unstructured":"Cannon MV, van Gilst WH, de Boer RA. Emerging role of liver X receptors in cardiac pathophysiology and heart failure. Basic Res Cardiol. 2016;111(1):3.","journal-title":"Basic Res Cardiol"},{"issue":"1","key":"962_CR240","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1161\/CIRCULATIONAHA.105.560177","volume":"113","author":"SU Naik","year":"2006","unstructured":"Naik SU, et al. Pharmacological activation of liver X receptors promotes reverse cholesterol transport in vivo. Circulation. 2006;113(1):90\u20137.","journal-title":"Circulation"},{"issue":"11","key":"962_CR241","doi-asserted-by":"publisher","first-page":"7604","DOI":"10.1073\/pnas.112059299","volume":"99","author":"SB Joseph","year":"2002","unstructured":"Joseph SB, et al. Synthetic LXR ligand inhibits the development of atherosclerosis in mice. Proc Natl Acad Sci U S A. 2002;99(11):7604\u20139.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"19","key":"962_CR242","doi-asserted-by":"publisher","first-page":"7493","DOI":"10.1073\/pnas.1205189109","volume":"109","author":"XJ Tan","year":"2012","unstructured":"Tan XJ, et al. Anxiety in liver X receptor beta knockout female mice with loss of glutamic acid decarboxylase in ventromedial prefrontal cortex. Proc Natl Acad Sci U S A. 2012;109(19):7493\u20138.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"962_CR243","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1021\/acsptsci.0c00149","volume":"4","author":"M Ben Aissa","year":"2021","unstructured":"Ben Aissa M, et al. Discovery of nonlipogenic ABCA1 inducing compounds with potential in Alzheimer\u2019s disease and Type 2 diabetes. ACS Pharmacol Transl Sci. 2021;4(1):143\u201354.","journal-title":"ACS Pharmacol Transl Sci"},{"key":"962_CR244","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.neulet.2016.12.065","volume":"639","author":"MS Kruse","year":"2017","unstructured":"Kruse MS, Suarez LG, Coirini H. Regulation of the expression of LXR in rat hypothalamic and hippocampal explants. Neurosci Lett. 2017;639:53\u20138.","journal-title":"Neurosci Lett"},{"issue":"45","key":"962_CR245","doi-asserted-by":"publisher","first-page":"14006","DOI":"10.1073\/pnas.1519358112","volume":"112","author":"Y Miao","year":"2015","unstructured":"Miao Y, et al. Liver X receptor beta controls thyroid hormone feedback in the brain and regulates browning of subcutaneous white adipose tissue. Proc Natl Acad Sci U S A. 2015;112(45):14006\u201311.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"9","key":"962_CR246","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0106983","volume":"9","author":"R Ghaddab-Zroud","year":"2014","unstructured":"Ghaddab-Zroud R, et al. Liver X receptor regulation of thyrotropin-releasing hormone transcription in mouse hypothalamus is dependent on thyroid status. PLoS ONE. 2014;9(9): e106983.","journal-title":"PLoS ONE"},{"key":"962_CR247","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.neulet.2016.04.007","volume":"621","author":"AG Sandoval-Hernandez","year":"2016","unstructured":"Sandoval-Hernandez AG, et al. LXR activation protects hippocampal microvasculature in very old triple transgenic mouse model of Alzheimer\u2019s disease. Neurosci Lett. 2016;621:15\u201321.","journal-title":"Neurosci Lett"},{"issue":"14","key":"962_CR248","doi-asserted-by":"publisher","first-page":"1450","DOI":"10.1161\/CIRCULATIONAHA.108.782300","volume":"118","author":"JR Morales","year":"2008","unstructured":"Morales JR, et al. Activation of liver X receptors promotes neuroprotection and reduces brain inflammation in experimental stroke. Circulation. 2008;118(14):1450\u20139.","journal-title":"Circulation"},{"issue":"23\u201324","key":"962_CR249","doi-asserted-by":"publisher","first-page":"3396","DOI":"10.1016\/j.febslet.2008.08.035","volume":"582","author":"L Sironi","year":"2008","unstructured":"Sironi L, et al. Treatment with LXR agonists after focal cerebral ischemia prevents brain damage. FEBS Lett. 2008;582(23\u201324):3396\u2013400.","journal-title":"FEBS Lett"},{"issue":"2","key":"962_CR250","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1111\/j.1750-3639.2011.00517.x","volume":"22","author":"A ElAli","year":"2012","unstructured":"ElAli A, Hermann DM. Liver X receptor activation enhances blood-brain barrier integrity in the ischemic brain and increases the abundance of ATP-binding cassette transporters ABCB1 and ABCC1 on brain capillary cells. Brain Pathol. 2012;22(2):175\u201387.","journal-title":"Brain Pathol"},{"issue":"5266","key":"962_CR251","doi-asserted-by":"publisher","first-page":"1336","DOI":"10.1126\/science.272.5266.1336","volume":"272","author":"W Seol","year":"1996","unstructured":"Seol W, Choi HS, Moore DD. An orphan nuclear hormone receptor that lacks a DNA binding domain and heterodimerizes with other receptors. Science. 1996;272(5266):1336\u20139.","journal-title":"Science"},{"key":"962_CR252","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/S0074-7696(07)61003-1","volume":"261","author":"YS Lee","year":"2007","unstructured":"Lee YS, et al. Structure and function of the atypical orphan nuclear receptor small heterodimer partner. Int Rev Cytol. 2007;261:117\u201358.","journal-title":"Int Rev Cytol"},{"issue":"5","key":"962_CR253","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1016\/j.bbalip.2017.02.006","volume":"1862","author":"R Rodriguez-Calvo","year":"2017","unstructured":"Rodriguez-Calvo R, et al. Small heterodimer partner (SHP) contributes to insulin resistance in cardiomyocytes. Biochim Biophys Acta Mol Cell Biol Lipids. 2017;1862(5):541\u201351.","journal-title":"Biochim Biophys Acta Mol Cell Biol Lipids"},{"issue":"5","key":"962_CR254","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1161\/CIRCRESAHA.115.304388","volume":"115","author":"YS Nam","year":"2014","unstructured":"Nam YS, et al. Small heterodimer partner blocks cardiac hypertrophy by interfering with GATA6 signaling. Circ Res. 2014;115(5):493\u2013503.","journal-title":"Circ Res"},{"issue":"4","key":"962_CR255","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1210\/er.2000-0035","volume":"23","author":"JY Chiang","year":"2002","unstructured":"Chiang JY. Bile acid regulation of gene expression: roles of nuclear hormone receptors. Endocr Rev. 2002;23(4):443\u201363.","journal-title":"Endocr Rev"},{"issue":"4","key":"962_CR256","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1210\/me.2003-0311","volume":"18","author":"JY Kim","year":"2004","unstructured":"Kim JY, et al. Orphan nuclear receptor small heterodimer partner, a novel corepressor for a basic helix-loop-helix transcription factor BETA2\/neuroD. Mol Endocrinol. 2004;18(4):776\u201390.","journal-title":"Mol Endocrinol"},{"issue":"10","key":"962_CR257","doi-asserted-by":"publisher","first-page":"1551","DOI":"10.1210\/mend.12.10.0184","volume":"12","author":"W Seol","year":"1998","unstructured":"Seol W, et al. Inhibition of estrogen receptor action by the orphan receptor SHP (short heterodimer partner). Mol Endocrinol. 1998;12(10):1551\u20137.","journal-title":"Mol Endocrinol"},{"issue":"7","key":"962_CR258","doi-asserted-by":"publisher","first-page":"1158","DOI":"10.1136\/jim-2016-000194","volume":"64","author":"L Wang","year":"2016","unstructured":"Wang L, Liangpunsakul S. Circadian clock control of hepatic lipid metabolism: role of small heterodimer partner (Shp). J Investig Med. 2016;64(7):1158\u201361.","journal-title":"J Investig Med"},{"issue":"439","key":"962_CR259","doi-asserted-by":"publisher","first-page":"ra78","DOI":"10.1126\/scisignal.aaf4850","volume":"9","author":"JH Lee","year":"2016","unstructured":"Lee JH, et al. Small heterodimer partner SHP mediates liver X receptor (LXR)-dependent suppression of inflammatory signaling by promoting LXR SUMOylation specifically in astrocytes. Sci Signal. 2016;9(439):ra78.","journal-title":"Sci Signal"},{"issue":"2","key":"962_CR260","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1053\/jhep.2003.50299","volume":"38","author":"J Locker","year":"2003","unstructured":"Locker J, et al. A common set of immediate-early response genes in liver regeneration and hyperplasia. Hepatology. 2003;38(2):314\u201325.","journal-title":"Hepatology"},{"issue":"11","key":"962_CR261","doi-asserted-by":"publisher","first-page":"1146","DOI":"10.1177\/0954411914557373","volume":"228","author":"K Reising","year":"2014","unstructured":"Reising K, et al. Biomechanical testing of an innovative fixation procedure to stabilize olecranon osteotomy. Proc Inst Mech Eng H. 2014;228(11):1146\u201353.","journal-title":"Proc Inst Mech Eng H"},{"issue":"5","key":"962_CR262","doi-asserted-by":"publisher","first-page":"1118","DOI":"10.1002\/hep.20883","volume":"42","author":"A Columbano","year":"2005","unstructured":"Columbano A, et al. Gadd45beta is induced through a CAR-dependent, TNF-independent pathway in murine liver hyperplasia. Hepatology. 2005;42(5):1118\u201326.","journal-title":"Hepatology"},{"issue":"38","key":"962_CR263","doi-asserted-by":"publisher","first-page":"25984","DOI":"10.1074\/jbc.M109.016808","volume":"284","author":"J Gao","year":"2009","unstructured":"Gao J, et al. The constitutive androstane receptor is an anti-obesity nuclear receptor that improves insulin sensitivity. J Biol Chem. 2009;284(38):25984\u201392.","journal-title":"J Biol Chem"},{"issue":"44","key":"962_CR264","doi-asserted-by":"publisher","first-page":"18831","DOI":"10.1073\/pnas.0909731106","volume":"106","author":"B Dong","year":"2009","unstructured":"Dong B, et al. Activation of nuclear receptor CAR ameliorates diabetes and fatty liver disease. Proc Natl Acad Sci U S A. 2009;106(44):18831\u20136.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"9","key":"962_CR265","doi-asserted-by":"publisher","first-page":"884","DOI":"10.5551\/jat.RV17009","volume":"24","author":"H Abe","year":"2017","unstructured":"Abe H, Semba H, Takeda N. The roles of hypoxia signaling in the pathogenesis of cardiovascular diseases. J Atheroscler Thromb. 2017;24(9):884\u201394.","journal-title":"J Atheroscler Thromb"},{"issue":"2","key":"962_CR266","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1124\/jpet.104.069310","volume":"311","author":"JK Lamba","year":"2004","unstructured":"Lamba JK, et al. Expression of constitutive androstane receptor splice variants in human tissues and their functional consequences. J Pharmacol Exp Ther. 2004;311(2):811\u201321.","journal-title":"J Pharmacol Exp Ther"},{"issue":"7","key":"962_CR267","doi-asserted-by":"publisher","first-page":"1528","DOI":"10.1124\/dmd.109.027011","volume":"37","author":"F Dutheil","year":"2009","unstructured":"Dutheil F, et al. Xenobiotic-metabolizing enzymes and transporters in the normal human brain: regional and cellular mapping as a basis for putative roles in cerebral function. Drug Metab Dispos. 2009;37(7):1528\u201338.","journal-title":"Drug Metab Dispos"},{"issue":"5","key":"962_CR268","doi-asserted-by":"publisher","first-page":"3113","DOI":"10.1007\/s12035-018-1285-4","volume":"56","author":"M Kajta","year":"2019","unstructured":"Kajta M, et al. Triclocarban disrupts the epigenetic status of neuronal cells and induces AHR\/CAR-mediated apoptosis. Mol Neurobiol. 2019;56(5):3113\u201331.","journal-title":"Mol Neurobiol"},{"key":"962_CR269","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.jsbmb.2015.11.018","volume":"156","author":"E Litwa","year":"2016","unstructured":"Litwa E, et al. RXRalpha, PXR and CAR xenobiotic receptors mediate the apoptotic and neurotoxic actions of nonylphenol in mouse hippocampal cells. J Steroid Biochem Mol Biol. 2016;156:43\u201352.","journal-title":"J Steroid Biochem Mol Biol"},{"issue":"3","key":"962_CR270","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1210\/edrv.18.3.0301","volume":"18","author":"KL Parker","year":"1997","unstructured":"Parker KL, Schimmer BP. Steroidogenic factor 1: a key determinant of endocrine development and function. Endocr Rev. 1997;18(3):361\u201377.","journal-title":"Endocr Rev"},{"issue":"4","key":"962_CR271","first-page":"478","volume":"9","author":"Y Ikeda","year":"1995","unstructured":"Ikeda Y, et al. The nuclear receptor steroidogenic factor 1 is essential for the formation of the ventromedial hypothalamic nucleus. Mol Endocrinol. 1995;9(4):478\u201386.","journal-title":"Mol Endocrinol"},{"issue":"2","key":"962_CR272","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/j.neuron.2005.12.021","volume":"49","author":"H Dhillon","year":"2006","unstructured":"Dhillon H, et al. Leptin directly activates SF1 neurons in the VMH, and this action by leptin is required for normal body-weight homeostasis. Neuron. 2006;49(2):191\u2013203.","journal-title":"Neuron"},{"issue":"4","key":"962_CR273","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1002\/1096-9861(20000807)423:4<579::AID-CNE4>3.0.CO;2-#","volume":"423","author":"TL Dellovade","year":"2000","unstructured":"Dellovade TL, et al. Disruption of the gene encoding SF-1 alters the distribution of hypothalamic neuronal phenotypes. J Comp Neurol. 2000;423(4):579\u201389.","journal-title":"J Comp Neurol"},{"issue":"2","key":"962_CR274","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1016\/j.expneurol.2011.08.021","volume":"232","author":"T Budefeld","year":"2011","unstructured":"Budefeld T, Tobet SA, Majdic G. Altered position of cell bodies and fibers in the ventromedial region in SF-1 knockout mice. Exp Neurol. 2011;232(2):176\u201384.","journal-title":"Exp Neurol"},{"issue":"1","key":"962_CR275","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1038\/oby.2003.10","volume":"11","author":"P Valensi","year":"2003","unstructured":"Valensi P, et al. Cardiovascular vagosympathetic activity in rats with ventromedial hypothalamic obesity. Obes Res. 2003;11(1):54\u201364.","journal-title":"Obes Res"},{"issue":"1","key":"962_CR276","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/0006-8993(81)90069-X","volume":"211","author":"P Gauthier","year":"1981","unstructured":"Gauthier P, Reis DJ, Nathan MA. Arterial hypertension elicited either by lesions or by electrical stimulations of the rostral hypothalamus in the rat. Brain Res. 1981;211(1):91\u2013105.","journal-title":"Brain Res"},{"issue":"2","key":"962_CR277","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/j.physbeh.2005.10.007","volume":"87","author":"BM King","year":"2006","unstructured":"King BM. The rise, fall, and resurrection of the ventromedial hypothalamus in the regulation of feeding behavior and body weight. Physiol Behav. 2006;87(2):221\u201344.","journal-title":"Physiol Behav"},{"key":"962_CR278","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2021.737135","volume":"8","author":"Y Zhou","year":"2021","unstructured":"Zhou Y, et al. Ventromedial hypothalamus activation aggravates hypertension myocardial remodeling through the sympathetic nervous system. Front Cardiovasc Med. 2021;8: 737135.","journal-title":"Front Cardiovasc Med"},{"issue":"4","key":"962_CR279","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1038\/nrcardio.2017.189","volume":"15","author":"M Kivimaki","year":"2018","unstructured":"Kivimaki M, Steptoe A. Effects of stress on the development and progression of cardiovascular disease. Nat Rev Cardiol. 2018;15(4):215\u201329.","journal-title":"Nat Rev Cardiol"},{"key":"962_CR280","doi-asserted-by":"publisher","first-page":"150","DOI":"10.3389\/fnsys.2015.00150","volume":"9","author":"SM Labbe","year":"2015","unstructured":"Labbe SM, et al. Hypothalamic control of brown adipose tissue thermogenesis. Front Syst Neurosci. 2015;9:150.","journal-title":"Front Syst Neurosci"},{"issue":"1","key":"962_CR281","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1016\/j.cmet.2017.06.014","volume":"26","author":"N Martinez-Sanchez","year":"2017","unstructured":"Martinez-Sanchez N, et al. Hypothalamic AMPK-ER stress-JNK1 axis mediates the central actions of thyroid hormones on energy balance. Cell Metab. 2017;26(1):212-229 e12.","journal-title":"Cell Metab"},{"issue":"1","key":"962_CR282","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/j.cmet.2010.05.002","volume":"12","author":"Y Xu","year":"2010","unstructured":"Xu Y, et al. PI3K signaling in the ventromedial hypothalamic nucleus is required for normal energy homeostasis. Cell Metab. 2010;12(1):88\u201395.","journal-title":"Cell Metab"},{"issue":"4","key":"962_CR283","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1016\/j.cmet.2011.08.009","volume":"14","author":"Y Xu","year":"2011","unstructured":"Xu Y, et al. Distinct hypothalamic neurons mediate estrogenic effects on energy homeostasis and reproduction. Cell Metab. 2011;14(4):453\u201365.","journal-title":"Cell Metab"},{"issue":"11","key":"962_CR284","doi-asserted-by":"publisher","first-page":"2213","DOI":"10.2337\/db17-1538","volume":"67","author":"P Seoane-Collazo","year":"2018","unstructured":"Seoane-Collazo P, et al. SF1-specific AMPKalpha1 deletion protects against diet-induced obesity. Diabetes. 2018;67(11):2213\u201326.","journal-title":"Diabetes"},{"issue":"9","key":"962_CR285","doi-asserted-by":"publisher","DOI":"10.15252\/embr.201949807","volume":"21","author":"J Castillo-Armengol","year":"2020","unstructured":"Castillo-Armengol J, et al. Hypothalamic CDK4 regulates thermogenesis by modulating sympathetic innervation of adipose tissues. EMBO Rep. 2020;21(9): e49807.","journal-title":"EMBO Rep"},{"key":"962_CR286","doi-asserted-by":"publisher","DOI":"10.1016\/j.molmet.2021.101211","volume":"48","author":"M Rouabhi","year":"2021","unstructured":"Rouabhi M, et al. BBSome ablation in SF1 neurons causes obesity without comorbidities. Mol Metab. 2021;48: 101211.","journal-title":"Mol Metab"},{"issue":"2","key":"962_CR287","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1161\/HYPERTENSIONAHA.116.07461","volume":"68","author":"K Lim","year":"2016","unstructured":"Lim K, et al. Origin of aberrant blood pressure and sympathetic regulation in diet-induced obesity. Hypertension. 2016;68(2):491\u2013500.","journal-title":"Hypertension"},{"issue":"1\u20135","key":"962_CR288","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.jsbmb.2005.04.016","volume":"95","author":"CR Mendelson","year":"2005","unstructured":"Mendelson CR, et al. Transcriptional regulation of aromatase in placenta and ovary. J Steroid Biochem Mol Biol. 2005;95(1\u20135):25\u201333.","journal-title":"J Steroid Biochem Mol Biol"},{"issue":"1","key":"962_CR289","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1007\/s10735-007-9077-6","volume":"38","author":"H Higashiyama","year":"2007","unstructured":"Higashiyama H, Kinoshita M, Asano S. Expression profiling of liver receptor homologue 1 (LRH-1) in mouse tissues using tissue microarray. J Mol Histol. 2007;38(1):45\u201352.","journal-title":"J Mol Histol"},{"issue":"7","key":"962_CR290","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1080\/15384047.2015.1045693","volume":"16","author":"C Nadolny","year":"2015","unstructured":"Nadolny C, Dong X. Liver receptor homolog-1 (LRH-1): a potential therapeutic target for cancer. Cancer Biol Ther. 2015;16(7):997\u20131004.","journal-title":"Cancer Biol Ther"},{"issue":"5","key":"962_CR291","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1016\/j.tcb.2004.03.008","volume":"14","author":"E Fayard","year":"2004","unstructured":"Fayard E, Auwerx J, Schoonjans K. LRH-1: an orphan nuclear receptor involved in development, metabolism and steroidogenesis. Trends Cell Biol. 2004;14(5):250\u201360.","journal-title":"Trends Cell Biol"},{"issue":"7352","key":"962_CR292","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1038\/nature10111","volume":"474","author":"JM Lee","year":"2011","unstructured":"Lee JM, et al. A nuclear-receptor-dependent phosphatidylcholine pathway with antidiabetic effects. Nature. 2011;474(7352):506\u201310.","journal-title":"Nature"},{"issue":"8","key":"962_CR293","doi-asserted-by":"publisher","first-page":"2817","DOI":"10.1172\/JCI62368","volume":"122","author":"MH Oosterveer","year":"2012","unstructured":"Oosterveer MH, et al. LRH-1-dependent glucose sensing determines intermediary metabolism in liver. J Clin Invest. 2012;122(8):2817\u201326.","journal-title":"J Clin Invest"},{"key":"962_CR294","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.96151","author":"DA Miranda","year":"2018","unstructured":"Miranda DA, et al. LRH-1 regulates hepatic lipid homeostasis and maintains arachidonoyl phospholipid pools critical for phospholipid diversity. JCI Insight. 2018. https:\/\/doi.org\/10.1172\/jci.insight.96151.","journal-title":"JCI Insight"},{"issue":"5","key":"962_CR295","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1507\/endocrj.EJ14-0017","volume":"61","author":"T Hattori","year":"2014","unstructured":"Hattori T, et al. LRH-1 heterozygous knockout mice are prone to mild obesity. Endocr J. 2014;61(5):471\u201380.","journal-title":"Endocr J"},{"issue":"10","key":"962_CR296","doi-asserted-by":"publisher","first-page":"2378","DOI":"10.1210\/me.2004-0132","volume":"18","author":"P Delerive","year":"2004","unstructured":"Delerive P, et al. Identification of liver receptor homolog-1 as a novel regulator of apolipoprotein AI gene transcription. Mol Endocrinol. 2004;18(10):2378\u201387.","journal-title":"Mol Endocrinol"},{"issue":"4","key":"962_CR297","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1016\/S1674-8301(11)60036-5","volume":"25","author":"M Lu","year":"2011","unstructured":"Lu M, et al. ApoB\/apoA1 is an effective predictor of coronary heart disease risk in overweight and obesity. J Biomed Res. 2011;25(4):266\u201373.","journal-title":"J Biomed Res"},{"issue":"12","key":"962_CR298","volume":"8","author":"S Rahim","year":"2016","unstructured":"Rahim S, et al. Serum Apo A-1 and its role as a biomarker of coronary artery disease. Cureus. 2016;8(12): e941.","journal-title":"Cureus"},{"issue":"4","key":"962_CR299","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1210\/me.2012-1371","volume":"27","author":"SD Atkin","year":"2013","unstructured":"Atkin SD, et al. Nuclear receptor LRH-1 induces the reproductive neuropeptide kisspeptin in the hypothalamus. Mol Endocrinol. 2013;27(4):598\u2013605.","journal-title":"Mol Endocrinol"},{"issue":"23","key":"962_CR300","doi-asserted-by":"publisher","first-page":"1731","DOI":"10.1093\/jnci\/88.23.1731","volume":"88","author":"JH Lee","year":"1996","unstructured":"Lee JH, et al. KiSS-1, a novel human malignant melanoma metastasis-suppressor gene. J Natl Cancer Inst. 1996;88(23):1731\u20137.","journal-title":"J Natl Cancer Inst"},{"issue":"7","key":"962_CR301","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0179164","volume":"12","author":"Y Zhang","year":"2017","unstructured":"Zhang Y, et al. The effects of kisspeptin-10 on serum metabolism and myocardium in rats. PLoS ONE. 2017;12(7): e0179164.","journal-title":"PLoS ONE"},{"issue":"10","key":"962_CR302","doi-asserted-by":"publisher","first-page":"1891","DOI":"10.1210\/me.2010-0015","volume":"24","author":"MA Pearen","year":"2010","unstructured":"Pearen MA, Muscat GE. Minireview: nuclear hormone receptor 4A signaling: implications for metabolic disease. Mol Endocrinol. 2010;24(10):1891\u2013903.","journal-title":"Mol Endocrinol"},{"issue":"2","key":"962_CR303","doi-asserted-by":"publisher","first-page":"184","DOI":"10.3109\/10799893.2014.948555","volume":"35","author":"HS Ranhotra","year":"2015","unstructured":"Ranhotra HS. The NR4A orphan nuclear receptors: mediators in metabolism and diseases. J Recept Signal Transduct Res. 2015;35(2):184\u20138.","journal-title":"J Recept Signal Transduct Res"},{"issue":"11","key":"962_CR304","doi-asserted-by":"publisher","first-page":"2543","DOI":"10.1016\/j.bbamcr.2014.06.010","volume":"1843","author":"K Kurakula","year":"2014","unstructured":"Kurakula K, et al. NR4A nuclear receptors are orphans but not lonesome. Biochim Biophys Acta. 2014;1843(11):2543\u201355.","journal-title":"Biochim Biophys Acta"},{"issue":"10","key":"962_CR305","doi-asserted-by":"publisher","first-page":"3593","DOI":"10.1172\/JCI64145","volume":"122","author":"JD Hawk","year":"2012","unstructured":"Hawk JD, et al. NR4A nuclear receptors support memory enhancement by histone deacetylase inhibitors. J Clin Invest. 2012;122(10):3593\u2013602.","journal-title":"J Clin Invest"},{"issue":"6","key":"962_CR306","doi-asserted-by":"publisher","first-page":"2069","DOI":"10.2337\/db14-1206","volume":"64","author":"Y Chen","year":"2015","unstructured":"Chen Y, et al. Enhancement of hypothalamic STAT3 acetylation by nuclear receptor Nur77 dictates leptin sensitivity. Diabetes. 2015;64(6):2069\u201381.","journal-title":"Diabetes"},{"issue":"2","key":"962_CR307","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1016\/j.bbrc.2009.06.023","volume":"386","author":"K Nonogaki","year":"2009","unstructured":"Nonogaki K, et al. Serotonin 5-HT2C receptor-independent expression of hypothalamic NOR1, a novel modulator of food intake and energy balance, in mice. Biochem Biophys Res Commun. 2009;386(2):311\u20135.","journal-title":"Biochem Biophys Res Commun"},{"issue":"6","key":"962_CR308","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1016\/j.biopsych.2006.04.023","volume":"60","author":"F Gilbert","year":"2006","unstructured":"Gilbert F, et al. Nur77 gene knockout alters dopamine neuron biochemical activity and dopamine turnover. Biol Psychiatry. 2006;60(6):538\u201347.","journal-title":"Biol Psychiatry"},{"issue":"5310","key":"962_CR309","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1126\/science.276.5310.248","volume":"276","author":"RH Zetterstrom","year":"1997","unstructured":"Zetterstrom RH, et al. Dopamine neuron agenesis in Nurr1-deficient mice. Science. 1997;276(5310):248\u201350.","journal-title":"Science"},{"issue":"7","key":"962_CR310","doi-asserted-by":"publisher","first-page":"4013","DOI":"10.1073\/pnas.95.7.4013","volume":"95","author":"O Saucedo-Cardenas","year":"1998","unstructured":"Saucedo-Cardenas O, et al. Nurr1 is essential for the induction of the dopaminergic phenotype and the survival of ventral mesencephalic late dopaminergic precursor neurons. Proc Natl Acad Sci U S A. 1998;95(7):4013\u20138.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"962_CR311","doi-asserted-by":"publisher","DOI":"10.1002\/jnr.25067","author":"F Montarolo","year":"2022","unstructured":"Montarolo F, et al. NURR1-deficient mice have age- and sex-specific behavioral phenotypes. J Neurosci Res. 2022. https:\/\/doi.org\/10.1002\/jnr.25067.","journal-title":"J Neurosci Res"},{"issue":"2","key":"962_CR312","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1128\/MCB.21.2.663-677.2001","volume":"21","author":"AC Chung","year":"2001","unstructured":"Chung AC, et al. Loss of orphan receptor germ cell nuclear factor function results in ectopic development of the tail bud and a novel posterior truncation. Mol Cell Biol. 2001;21(2):663\u201377.","journal-title":"Mol Cell Biol"},{"issue":"3","key":"962_CR313","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/S1534-5807(01)00038-7","volume":"1","author":"G Fuhrmann","year":"2001","unstructured":"Fuhrmann G, et al. Mouse germline restriction of Oct4 expression by germ cell nuclear factor. Dev Cell. 2001;1(3):377\u201387.","journal-title":"Dev Cell"},{"issue":"1","key":"962_CR314","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1095\/biolreprod.102.008151","volume":"68","author":"ZJ Lan","year":"2003","unstructured":"Lan ZJ, et al. Expression of the orphan nuclear receptor, germ cell nuclear factor, in mouse gonads and preimplantation embryos. Biol Reprod. 2003;68(1):282\u20139.","journal-title":"Biol Reprod"},{"issue":"16","key":"962_CR315","doi-asserted-by":"publisher","first-page":"4070","DOI":"10.1093\/emboj\/cdg405","volume":"22","author":"ZJ Lan","year":"2003","unstructured":"Lan ZJ, et al. GCNF-dependent repression of BMP-15 and GDF-9 mediates gamete regulation of female fertility. EMBO J. 2003;22(16):4070\u201381.","journal-title":"EMBO J"},{"issue":"3","key":"962_CR316","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1111\/andr.12594","volume":"7","author":"M Bizkarguenaga","year":"2019","unstructured":"Bizkarguenaga M, et al. Increase of germ cell nuclear factor expression in globozoospermic Gopc(-\/-) knockout mice. Andrology. 2019;7(3):319\u201328.","journal-title":"Andrology"},{"issue":"19","key":"962_CR317","doi-asserted-by":"publisher","first-page":"8507","DOI":"10.1128\/MCB.25.19.8507-8519.2005","volume":"25","author":"P Gu","year":"2005","unstructured":"Gu P, et al. Orphan nuclear receptor GCNF is required for the repression of pluripotency genes during retinoic acid-induced embryonic stem cell differentiation. Mol Cell Biol. 2005;25(19):8507\u201319.","journal-title":"Mol Cell Biol"},{"issue":"1","key":"962_CR318","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.gep.2015.12.002","volume":"20","author":"JL Baker","year":"2016","unstructured":"Baker JL, et al. Testicular receptor 2, Nr2c1, is associated with stem cells in the developing olfactory epithelium and other cranial sensory and skeletal structures. Gene Expr Patterns. 2016;20(1):71\u20139.","journal-title":"Gene Expr Patterns"},{"issue":"1","key":"962_CR319","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1007\/s12311-008-0006-3","volume":"7","author":"YT Chen","year":"2008","unstructured":"Chen YT, et al. The roles of testicular orphan nuclear receptor 4 (TR4) in cerebellar development. Cerebellum. 2008;7(1):9\u201317.","journal-title":"Cerebellum"},{"key":"962_CR320","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.brainres.2007.06.069","volume":"1168","author":"YT Chen","year":"2007","unstructured":"Chen YT, et al. Abnormal cerebellar cytoarchitecture and impaired inhibitory signaling in adult mice lacking TR4 orphan nuclear receptor. Brain Res. 2007;1168:72\u201382.","journal-title":"Brain Res"},{"issue":"4","key":"962_CR321","doi-asserted-by":"publisher","first-page":"858","DOI":"10.1210\/me.2007-0181","volume":"22","author":"LM Chen","year":"2008","unstructured":"Chen LM, et al. Subfertility with defective folliculogenesis in female mice lacking testicular orphan nuclear receptor 4. Mol Endocrinol. 2008;22(4):858\u201367.","journal-title":"Mol Endocrinol"},{"issue":"42","key":"962_CR322","doi-asserted-by":"publisher","first-page":"15058","DOI":"10.1073\/pnas.0405700101","volume":"101","author":"LL Collins","year":"2004","unstructured":"Collins LL, et al. Growth retardation and abnormal maternal behavior in mice lacking testicular orphan nuclear receptor 4. Proc Natl Acad Sci U S A. 2004;101(42):15058\u201363.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"6","key":"962_CR323","doi-asserted-by":"publisher","first-page":"1399","DOI":"10.1093\/carcin\/bgu052","volume":"35","author":"SJ Lin","year":"2014","unstructured":"Lin SJ, et al. TR4 nuclear receptor functions as a tumor suppressor for prostate tumorigenesis via modulation of DNA damage\/repair system. Carcinogenesis. 2014;35(6):1399\u2013406.","journal-title":"Carcinogenesis"},{"issue":"10","key":"962_CR324","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1038\/cgt.2014.41","volume":"21","author":"B Chen","year":"2014","unstructured":"Chen B, et al. The role of testicular nuclear receptor 4 in chemo-resistance of docetaxel in castration-resistant prostate cancer. Cancer Gene Ther. 2014;21(10):411\u20135.","journal-title":"Cancer Gene Ther"},{"issue":"5","key":"962_CR325","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1210\/er.2001-0038","volume":"23","author":"SA Kliewer","year":"2002","unstructured":"Kliewer SA, Goodwin B, Willson TM. The nuclear pregnane X receptor: a key regulator of xenobiotic metabolism. Endocr Rev. 2002;23(5):687\u2013702.","journal-title":"Endocr Rev"},{"issue":"2","key":"962_CR326","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1124\/jpet.104.076331","volume":"312","author":"X Ding","year":"2005","unstructured":"Ding X, Staudinger JL. Induction of drug metabolism by forskolin: the role of the pregnane X receptor and the protein kinase a signal transduction pathway. J Pharmacol Exp Ther. 2005;312(2):849\u201356.","journal-title":"J Pharmacol Exp Ther"},{"issue":"7","key":"962_CR327","doi-asserted-by":"publisher","first-page":"1603","DOI":"10.1210\/me.2007-0133","volume":"21","author":"ML Ricketts","year":"2007","unstructured":"Ricketts ML, et al. The cholesterol-raising factor from coffee beans, cafestol, as an agonist ligand for the farnesoid and pregnane X receptors. Mol Endocrinol. 2007;21(7):1603\u201316.","journal-title":"Mol Endocrinol"},{"issue":"2","key":"962_CR328","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.113.000492","volume":"3","author":"Y Sui","year":"2014","unstructured":"Sui Y, et al. Bisphenol A increases atherosclerosis in pregnane X receptor-humanized ApoE deficient mice. J Am Heart Assoc. 2014;3(2): e000492.","journal-title":"J Am Heart Assoc"},{"issue":"3","key":"962_CR329","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1210\/er.2010-0021","volume":"32","author":"FJ Lin","year":"2011","unstructured":"Lin FJ, et al. Coup d\u2019Etat: an orphan takes control. Endocr Rev. 2011;32(3):404\u201321.","journal-title":"Endocr Rev"},{"issue":"5","key":"962_CR330","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1093\/hmg\/ddz233","volume":"29","author":"CA Chen","year":"2020","unstructured":"Chen CA, et al. Nr2f1 heterozygous knockout mice recapitulate neurological phenotypes of Bosch-Boonstra-Schaaf optic atrophy syndrome and show impaired hippocampal synaptic plasticity. Hum Mol Genet. 2020;29(5):705\u201315.","journal-title":"Hum Mol Genet"},{"key":"962_CR331","doi-asserted-by":"publisher","first-page":"8245","DOI":"10.1038\/ncomms9245","volume":"6","author":"SP Wu","year":"2015","unstructured":"Wu SP, et al. Increased COUP-TFII expression in adult hearts induces mitochondrial dysfunction resulting in heart failure. Nat Commun. 2015;6:8245.","journal-title":"Nat Commun"},{"issue":"12","key":"962_CR332","doi-asserted-by":"publisher","first-page":"2820","DOI":"10.1093\/cercor\/bhr359","volume":"22","author":"G Reinchisi","year":"2012","unstructured":"Reinchisi G, et al. COUP-TFII expressing interneurons in human fetal forebrain. Cereb Cortex. 2012;22(12):2820\u201330.","journal-title":"Cereb Cortex"},{"issue":"10","key":"962_CR333","doi-asserted-by":"publisher","first-page":"4971","DOI":"10.1093\/cercor\/bhx185","volume":"27","author":"A Alzu'bi","year":"2017","unstructured":"Alzu\u2019bi A, et al. The transcription factors COUP-TFI and COUP-TFII have distinct roles in arealisation and GABAergic interneuron specification in the early human fetal telencephalon. Cereb Cortex. 2017;27(10):4971\u201387.","journal-title":"Cereb Cortex"},{"issue":"36","key":"962_CR334","doi-asserted-by":"publisher","first-page":"E4985","DOI":"10.1073\/pnas.1420701112","volume":"112","author":"S Kanatani","year":"2015","unstructured":"Kanatani S, et al. The COUP-TFII\/Neuropilin-2 is a molecular switch steering diencephalon-derived GABAergic neurons in the developing mouse brain. Proc Natl Acad Sci U S A. 2015;112(36):E4985\u201394.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"5","key":"962_CR335","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/S1043-2760(98)00048-4","volume":"9","author":"RN Yu","year":"1998","unstructured":"Yu RN, et al. The role of DAX-1 in reproduction. Trends Endocrinol Metab. 1998;9(5):169\u201375.","journal-title":"Trends Endocrinol Metab"},{"issue":"8","key":"962_CR336","doi-asserted-by":"publisher","first-page":"1445","DOI":"10.1210\/me.2003-0159","volume":"17","author":"E Lalli","year":"2003","unstructured":"Lalli E, Sassone-Corsi P. DAX-1, an unusual orphan receptor at the crossroads of steroidogenic function and sexual differentiation. Mol Endocrinol. 2003;17(8):1445\u201353.","journal-title":"Mol Endocrinol"},{"issue":"4","key":"962_CR337","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1081\/ERC-120016835","volume":"28","author":"T Suzuki","year":"2002","unstructured":"Suzuki T, et al. LXXLL motifs in Dax-1 have target specificity for the orphan nuclear receptors Ad4BP\/SF-1 and LRH-1. Endocr Res. 2002;28(4):537.","journal-title":"Endocr Res"},{"issue":"3","key":"962_CR338","doi-asserted-by":"publisher","first-page":"1476","DOI":"10.1128\/MCB.17.3.1476","volume":"17","author":"M Ito","year":"1997","unstructured":"Ito M, Yu R, Jameson JL. DAX-1 inhibits SF-1-mediated transactivation via a carboxy-terminal domain that is deleted in adrenal hypoplasia congenita. Mol Cell Biol. 1997;17(3):1476\u201383.","journal-title":"Mol Cell Biol"},{"issue":"51","key":"962_CR339","doi-asserted-by":"publisher","first-page":"39855","DOI":"10.1074\/jbc.C000567200","volume":"275","author":"H Zhang","year":"2000","unstructured":"Zhang H, et al. DAX-1 functions as an LXXLL-containing corepressor for activated estrogen receptors. J Biol Chem. 2000;275(51):39855\u20139.","journal-title":"J Biol Chem"},{"issue":"33","key":"962_CR340","doi-asserted-by":"publisher","first-page":"31136","DOI":"10.1074\/jbc.M305153200","volume":"278","author":"IU Agoulnik","year":"2003","unstructured":"Agoulnik IU, et al. Repressors of androgen and progesterone receptor action. J Biol Chem. 2003;278(33):31136\u201348.","journal-title":"J Biol Chem"},{"issue":"4","key":"962_CR341","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1038\/3822","volume":"20","author":"RN Yu","year":"1998","unstructured":"Yu RN, et al. Role of Ahch in gonadal development and gametogenesis. Nat Genet. 1998;20(4):353\u20137.","journal-title":"Nat Genet"},{"issue":"3","key":"962_CR342","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1172\/JCI7212","volume":"105","author":"A Tabarin","year":"2000","unstructured":"Tabarin A, et al. A novel mutation in DAX1 causes delayed-onset adrenal insufficiency and incomplete hypogonadotropic hypogonadism. J Clin Invest. 2000;105(3):321\u20138.","journal-title":"J Clin Invest"},{"issue":"Suppl 1","key":"962_CR343","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1159\/000354208","volume":"22","author":"AE Omu","year":"2013","unstructured":"Omu AE. Sperm parameters: paradigmatic index of good health and longevity. Med Princ Pract. 2013;22(Suppl 1):30\u201342.","journal-title":"Med Princ Pract"},{"issue":"3","key":"962_CR344","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1210\/mend.16.3.0804","volume":"16","author":"E Holter","year":"2002","unstructured":"Holter E, et al. Inhibition of androgen receptor (AR) function by the reproductive orphan nuclear receptor DAX-1. Mol Endocrinol. 2002;16(3):515\u201328.","journal-title":"Mol Endocrinol"},{"issue":"6488","key":"962_CR345","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1038\/370375a0","volume":"370","author":"RT Yu","year":"1994","unstructured":"Yu RT, et al. Relationship between Drosophila gap gene tailless and a vertebrate nuclear receptor Tlx. Nature. 1994;370(6488):375\u20139.","journal-title":"Nature"},{"issue":"7181","key":"962_CR346","doi-asserted-by":"publisher","first-page":"1004","DOI":"10.1038\/nature06562","volume":"451","author":"CL Zhang","year":"2008","unstructured":"Zhang CL, et al. A role for adult TLX-positive neural stem cells in learning and behaviour. Nature. 2008;451(7181):1004\u20137.","journal-title":"Nature"},{"issue":"25","key":"962_CR347","doi-asserted-by":"publisher","first-page":"9115","DOI":"10.1073\/pnas.1406779111","volume":"111","author":"K Murai","year":"2014","unstructured":"Murai K, et al. Nuclear receptor TLX stimulates hippocampal neurogenesis and enhances learning and memory in a transgenic mouse model. Proc Natl Acad Sci U S A. 2014;111(25):9115\u201320.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"962_CR348","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2015.220","volume":"6","author":"J Song","year":"2015","unstructured":"Song J, et al. Adiponectin receptor-mediated signaling ameliorates cerebral cell damage and regulates the neurogenesis of neural stem cells at high glucose concentrations: an in vivo and in vitro study. Cell Death Dis. 2015;6: e1844.","journal-title":"Cell Death Dis"},{"issue":"9","key":"962_CR349","doi-asserted-by":"publisher","first-page":"4814","DOI":"10.1073\/pnas.96.9.4814","volume":"96","author":"M Kobayashi","year":"1999","unstructured":"Kobayashi M, et al. Identification of a photoreceptor cell-specific nuclear receptor. Proc Natl Acad Sci U S A. 1999;96(9):4814\u20139.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"3","key":"962_CR350","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1128\/MCB.16.3.925","volume":"16","author":"T Drewes","year":"1996","unstructured":"Drewes T, et al. Human hepatocyte nuclear factor 4 isoforms are encoded by distinct and differentially expressed genes. Mol Cell Biol. 1996;16(3):925\u201331.","journal-title":"Mol Cell Biol"},{"key":"962_CR351","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/1478-1336-1-5","volume":"1","author":"S Jiang","year":"2003","unstructured":"Jiang S, et al. Expression and localization of P1 promoter-driven hepatocyte nuclear factor-4alpha (HNF4alpha) isoforms in human and rats. Nucl Recept. 2003;1:5.","journal-title":"Nucl Recept"},{"issue":"5","key":"962_CR352","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0005609","volume":"4","author":"X Yuan","year":"2009","unstructured":"Yuan X, et al. Identification of an endogenous ligand bound to a native orphan nuclear receptor. PLoS ONE. 2009;4(5): e5609.","journal-title":"PLoS ONE"},{"issue":"Pt 1","key":"962_CR353","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1042\/bst0320092","volume":"32","author":"M Crestani","year":"2004","unstructured":"Crestani M, et al. LXR (liver X receptor) and HNF-4 (hepatocyte nuclear factor-4): key regulators in reverse cholesterol transport. Biochem Soc Trans. 2004;32(Pt 1):92\u20136.","journal-title":"Biochem Soc Trans"},{"issue":"18","key":"962_CR354","doi-asserted-by":"publisher","first-page":"1445","DOI":"10.1001\/jama.279.18.1445","volume":"279","author":"BW Walsh","year":"1998","unstructured":"Walsh BW, et al. Effects of raloxifene on serum lipids and coagulation factors in healthy postmenopausal women. JAMA. 1998;279(18):1445\u201351.","journal-title":"JAMA"},{"issue":"10263","key":"962_CR355","doi-asserted-by":"publisher","first-page":"1644","DOI":"10.1016\/S0140-6736(20)32233-9","volume":"396","author":"MB Mortensen","year":"2020","unstructured":"Mortensen MB, Nordestgaard BG. Elevated LDL cholesterol and increased risk of myocardial infarction and atherosclerotic cardiovascular disease in individuals aged 70\u2013100 years: a contemporary primary prevention cohort. Lancet. 2020;396(10263):1644\u201352.","journal-title":"Lancet"},{"issue":"14","key":"962_CR356","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1056\/NEJM199610033351401","volume":"335","author":"FM Sacks","year":"1996","unstructured":"Sacks FM, et al. The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and recurrent events trial investigators. N Engl J Med. 1996;335(14):1001\u20139.","journal-title":"N Engl J Med"},{"issue":"9493","key":"962_CR357","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.1016\/S0140-6736(05)67528-9","volume":"366","author":"JA Dormandy","year":"2005","unstructured":"Dormandy JA, et al. Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive Study (PROspective pioglitAzone Clinical Trial In macroVascular Events): a randomised controlled trial. Lancet. 2005;366(9493):1279\u201389.","journal-title":"Lancet"},{"issue":"5","key":"962_CR358","doi-asserted-by":"publisher","first-page":"1032","DOI":"10.2215\/CJN.09291010","volume":"6","author":"JM Lachin","year":"2011","unstructured":"Lachin JM, et al. Renal function in type 2 diabetes with rosiglitazone, metformin, and glyburide monotherapy. Clin J Am Soc Nephrol. 2011;6(5):1032\u201340.","journal-title":"Clin J Am Soc Nephrol"},{"issue":"1","key":"962_CR359","doi-asserted-by":"publisher","first-page":"10","DOI":"10.7326\/0003-4819-138-1-200301070-00006","volume":"138","author":"AW Haider","year":"2003","unstructured":"Haider AW, et al. Systolic blood pressure, diastolic blood pressure, and pulse pressure as predictors of risk for congestive heart failure in the Framingham Heart Study. Ann Intern Med. 2003;138(1):10\u20136.","journal-title":"Ann Intern Med"}],"container-title":["Cell &amp; Bioscience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13578-023-00962-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13578-023-00962-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13578-023-00962-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,21]],"date-time":"2023-01-21T03:59:48Z","timestamp":1674273588000},"score":1,"resource":{"primary":{"URL":"https:\/\/cellandbioscience.biomedcentral.com\/articles\/10.1186\/s13578-023-00962-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,20]]},"references-count":359,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["962"],"URL":"https:\/\/doi.org\/10.1186\/s13578-023-00962-3","relation":{},"ISSN":["2045-3701"],"issn-type":[{"value":"2045-3701","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,1,20]]},"assertion":[{"value":"21 December 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 January 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 January 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no conflict of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"14"}}